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Resumo 
 
 
A poliadenilação alternativa (APA) é um mecanismo importante de regulação 
genética que ocorre em 70% dos organismos eucariotas. Este mecanismo 
compreende a formação de extremidades 3’ alternativas por poliadenilação em 
diferentes locais do mRNA, de acordo com os sinais de poliadenilação (pAs). Na 
APA, a escolha dos pAs é um mecanismo co-transcripcional que depende de 
factores auxiliares cis e trans necessários para os processos de clivagem e 
poliadenilação de todos os pré-mRNAs. Além disso, o uso dos pAs proximais ou 
distais está relacionado com eventos fisiológicos gerais. Consensualmente 
assume-se que em estados de proliferação ocorre o encurtamento, enquanto em 
estados de desenvolvimento e diferenciação ocorre o alongamento das 
extremidades 3’ não traduzidas (3’UTRs). Este padrão de APA é confirmado em 
tecidos cerebrais, onde a maior parte das células são diferenciadas, no entanto 
não existe uma alteração completa para a isoforma de mRNA longa uma vez que 
a isoforma curta continua a ser expressa. As Rho GTPases são ‘interruptores’ 
moleculares essenciais a vários processos celulares, incluindo a diferenciação, 
no entanto nada é conhecido sobre a sua regulação transcripcional. Assim, 
começamos a explorar se estes genes são regulados por APA. Descobrimos por 
análise de 3´RACE que, as Rho GTPases clássicas, expressam duas formas 
alternativas de mRNA. Contudo durante a diferenciação dos oligodendrócitos 
(OLs), eles expressam preferencialmente a isoforma mRNA mais curta, e não se 
observou uma alteração para a escolha da isoforma mais longa, em contraste 
com os dados de estudos globais do genoma em tecido cerebral. Uma vez que 
estas proteínas são altamente reguladas por GEFs e por GAPs, provavelmente 
não necessitam de regulação a nível transcripcional. As Rho GTPases atípicas, 
que estão constitutivamente activas, apresentam um indução global dos pAs 
distais, distintas das Rho GTPases clássicas. Curiosamente, este padrão sugere 
que APA é um mecanismo específico do gene. Como 3’UTRs mais longas 
providenciam mais locais de ligação para microRNA ou proteínas de ligação ao 
RNA (RBPs), isto sugere que as Rho GTPases atípicas requerem uma regulação 
mais fina ao nível co-transcriptional, por APA. Adicionalmente, mostramos que a 
APA é também específica de cada tipo celular, pela análise da expressão do 
mRNA em outras células da glia (microglia, astrócitos), e em diferentes tipos de 
neurónios (corticais, estriatais e hipocampais). Nós observamos o mesmo padrão 
de APA para as Rho GTPases selecionadas em todas as células da glia. No 
entanto, em neurónios corticais e do estriado, observámos a existência do 
alongamento do 3’UTR no mRNA da Rac1 durante o crescimento axonal, o que 
resulta num aumento da quantidade total de proteína. Em resumo, estes 
resultados indicam, pela primeira vez, que a APA é um mecanismo específico de 
cada gene e de cada tipo celular. Para além disso, descobrimos uma expressão 
diferencial de ambas as isoformas da Cdc42 durante a diferenciação dos OLs e 
do nervo ciático. Durante a diferenciação in vitro de OLs e in vivo do nervo 
ciático, observámos um aumento do rácio da expressão entre Cdc42 Iso1/Cdc42 
Iso2. Mais ainda, a expressão constitutiva de Cdc42 Iso2 em OLs induz um 
atraso na diferenciação, enquanto a expressão constitutiva da Cdc42 Iso1 induz 
um aumento das ramificações, sugerindo uma exacerbação do fenótipo de 
diferenciação. Assim, estas observações sugerem um papel distinto para as 
diferentes isoformas de Cdc42 durante a diferenciação de OLs. Globalmente, 
esta tese abre novos caminhos para explorar no futuro, que podem ter um 
impacto no nosso conhecimento, na regulação do processo de 
mielinização/remielinização. 
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Abstract 
 
Alternative polyadenylation (APA) is an important mechanism of gene regulation 
that occurs in 70% of eukaryotic organisms. This process comprises the formation 
of alternative 3’ ends of an mRNA by cleavage of the pre-mRNA and 
polyadenylation at different sites according to the polyadenylation signals (pAs). 
The choice of pAs in APA is a co-transcriptional mechanism that depends on 
auxiliary cis- and trans-acting factors. The usage of the proximal or the distal pAs 
has been related to global physiologic events. It is consensually assumed that in 
proliferative conditions there is preferential usage of proximal pAs, while during 
development and in differentiated cellular states occurs lengthening of the 3’UTRs 
by selection of the distal pAs. This pattern is also confirmed in brain tissues, where 
most of the cells are differentiated, and where it was observed a lengthening of the 
3’ UTRs. However, there is not a complete switch for the distal pA, since the 
shortest mRNA is still expressed. Rho GTPases are key molecular switchers 
essential for several cellular processes, including differentiation, however nothing is 
known about transcriptional regulation in these genes. Therefore, we started to 
explore if Rho GTPases genes undergo APA. We found by 3’RACE analyses, that 
classical Rho GTPAses express two alternative mRNA isoforms. However during 
oligodendrocytes differentiation, they preferentially express the shortest mRNA 
isoform, and we did not observe a switch towards the distal pA usage, in contrast 
with the published genome-wide data obtained from brain tissues. Since Rho 
GTPases are tightly regulated at the protein level by GEFs and GAPs, they may not 
require this mode of co-transcriptional regulation. The atypical RhoBTB2, which is 
constitutively active, present a global induction of distal pA sites, distinct from the 
classical Rho GTPases. Interestingly, this pattern suggests that APA is a gene 
specific mechanism. As longer 3'UTRs contain more binding sites for miRNAs and 
RNA binding proteins (RBPs) this suggests that atypical Rho GTPases require a 
fine-tune regulation at the co-transcriptional level, by APA. Additionally, we showed 
that APA is also cell-specific, by analyzing the expression of the different mRNA 
isoforms of Rho GTPases in other glial cells (microglia, astrocytes) and different 
types of neurons (cortical, striatal and hippocampal). We observed the same APA 
profile for the selected Rho GTPases in all glial cells types. However, in cortical and 
striatal neurons we observed a lengthening in the 3’UTR Rac1 mRNA during 
axonal growth, which results in the increase of the total protein levels. Taken 
together, our results indicate for the first time that APA is a gene- and cell- specific 
mechanism. In addition, we have found a differential expression of both Cdc42 
isoforms during OL and sciatic nerve differentiation. During in vitro OL and in vivo 
sciatic nerve differentiation we observed an increase in the expression ratio 
between Cdc42 Iso1/Cdc42 Iso2. Further, constitutive expression of Cdc42 Iso2 in 
OLs induces a delay in differentiation, whereas constitutive expression of Cdc42 
Iso1 induces an increase in OL branching, suggesting an exacerbation of the 
differentiated phenotype. Thus, these observations suggest a distinct role for the 
different Cdc42 isoforms during OL differentiation. Overall, this thesis opens new 
avenues to explore in the future that can impact our understanding on the 
regulation of the myelination/remyelination processes. 
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1. Central Nervous System Cells 
 
1.1. Neurons 
 
The nervous system of higher vertebrates, besides its role in coordination the vital 
functions,  enables its members to perform fast and coordinated movements, respond to 
pain stimuli, and exert complex cognitive functions such as learning, memory and social 
behavior. The cellular basis of the vertebrate nervous system is built upon two major cell 
types: neurons and glia cells. Neurons are the main signal relaying cells and differ from 
other cell types present in the nervous system in their organization of fibrillar or tubular 
proteins that constitute the cytoskeleton.1 During maturation, neurons undergo a transition 
trough several stages of differentiation until becoming fully mature, i.e.  acquiring axon-
dendrite polarity.2 During this process, neurons develop lamellipodial and filopodial 
protrusions (at embryonic day 18 (E18)), followed by extension of multiple immature 
neuritis (at E18+1-2 days of in vitro culture (div)) which undergo axonal specification 
(E18+2-4div) and branching (E18+4-15div), and harbour dendritic spines and axon 
initiation at the fully differentiated stage (at E18+15-25div).3 The molecular mechanisms 
underlying neuronal development comprise: local protein translation and degradation; a 
wide range of signalling pathways; transcription regulation by microRNAs4 (miRNAs) or 
RNA-binding proteins (RBPs)5; and extracellular cues3. Although sharing the mechanisms 
involved in neuronal growth, different neurons have particular gene expression6 and gene 
regulation7 programs according to their sub type.  
 
1.2. Glial Cells 
 
Glial cells, derived from the Greek word “γλία”, meaning “glue”, provide important support 
to the neurons. In the CNS, there are three types of glial cells: astrocytes that provide 
trophic and structural support to the neurons and act in several other aspects of the 
neuronal homeostasis and metabolism; oligodendrocytes (OL) that produce myelin 
sheaths around axons in order to increase nervous conduction speed and microglia, the 
resident immune cells. In the peripheral nervous system (PNS) the glial population is 
constituted by Schwann cells (SC).8 Glial cells, are essential for the correct development, 
maintenance and function of the brain network. They are the most abundant cells in the 
mammalian brain, and exist in a ratio of 3 glial cells for 1 neuron.1 Although glia cells also 
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extend complex processes, these are less prominent and have completely different 
functions than those of neurons. During OL maturation, bipolar and proliferative progenitor 
cells (OPC) will give rise to more differentiated myelinating-competent OL containing long 
radial processes and branching (Figure1). Between these two developmental stages OPC 
undergo a complete cellular reprogramming in which they stop proliferating and initiate a 
differentiation program.9, 10 This developmental program is regulated in response to 
extracellular cues, which are sensed by the OL.  Such cues could be integrin, growth 
factor or chemokine receptor activation. Since OPC have a strong tendency to 
differentiate in absence of proliferative stimulus, this proliferation-differentiation transition 
needs to have fine-tune regulation. Similar to neurons, OL differentiation is regulated 
trough several mechanisms, such as epigenetic control11, 12; gene expression programs 
(whereas during morphological alterations, cells express a well defined panel of markers 
that define each stage)10, 13; and transcriptional and post-transcriptional regulation 14. As 
OL-neuron interactions are fundamental for neurons to function, the other way around is 
equally vital for OL development and myelination. The OL depends on neuronal signals, 
such as platelet-derived growth factor alpha (PDGF-A) or fibroblast growth factor (FGF-2), 
to decide the time and place for differentiation15.  
Figure 1. Oligodendrocyte development and differentiation. Representative scheme of the morphology 
alteration of oligodendrocytes during development and differentiation and an in vivo image of a mature 
oligodendrocyte (in green) myelinating an axon (in red). (Adapted from Jackman N. et al. 2009, 
Physiology) 
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2. Rho GTPases 
 
Rho (Ras homologue) family of small guanosine triphosphatases (Rho GTPases) includes 
a large subgroup of the Ras superfamily of 20-30kDa GTP-binding proteins.16 They act as 
molecular switches integrating signals from the environment to intracellular signal 
transduction pathways, thereby controlling a wide range of essential biochemical 
responses in eukaryotic cells.17 The network involving Rho GTPases is thought to be very 
complex since approximately one percent of the human genome encodes proteins that 
either regulate or are regulated by direct interaction with members of the Rho family.18 
Rho GTPases are ubiquitously expressed from yeast to mammalians, and within these 
they share over 50% of sequence identity.19 They are divided in 6 subfamilies, according 
to their sequence similarity and/or functionality: the classical RhoA (Ras homolog gene 
family, member A)-, Rac1 (Ras-related C3 botulinum toxin substrate 1)- and Cdc42 (Cell 
division control protein 42 homolog)-related subfamilies; and the atypical Rnd and 
RhoBTB (Rho-related BTB (Broad Complex/Tramtrack/Bric-a-brac) domain) subfamilies 
(Figure 2).20, 21 As molecular switches, typical Rho GTPases cycle between two 
conformatial states: inactive, in GDP-bound state or active, when binding to GTP. This 
alternation is controlated by three classes of regulatores: GTPase exchange factors 
(GEFs), which promotes the dissociation of GDP to allow the binding of GTP; GTPase-
activating proteins (GAPs), which increase the activity of Rho GTPases by promoting the 
Figure 2. Dendrogram showing the classification of Rho/Rac subfamily members according to 
structural similarity criteria. Members of each subfamily are highlighted using the same color code and 
grouped by shaded areas. The first symbol used for each GTPase corresponds to that approved by the 
Human Genome Organization Gene Nomenclature Committee. (Bustelo X. et al. 2007, Bioessays) 
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return to the inactive state; and guanine nucleotide dissociation inhibitors (GDIs), that 
stabilize the GDP-bound form and inhibit the association of GTPases to the membrane 
(Figure 3).22 In addition to this specfic regulation, Rho GTPases are also tightly regulated 
at expression level.21 When activated, these GTPases interact with their downstream 
effectors, which in turn regulate a wide range of mechanisms such as microtubles 
dynamics, transcription activation or membrane trafficking. These interactions, as well the 
resulting functions, are likely to be specific for each cell-type and physiologic condition. 
Rho GTPases are therefore fundamental for diverse cellular processes including cell 
growth, cytokinesis, cell motility, cell adhesion, cell transformation, invasion and neuronal 
development. Our knowledge about Rho GTPases arises mostly from the best studied 
proteins Rac1, Cdc42 and RhoA.17, 23-26  
 
Figure 3. GEFs, GAPs and GDIs regulating Rho GTPases. The activity of the Rho GTPases is modulated 
by Rho regulatory proteins of the following classes: GEFs, which activate Rho; GAPs, that facilitate 
inactivation of GTP-bound Rho by increasing GTPase activity; and GDIs that prevent dissociation of GDP and 
inhibit activation. Phosphatases could potentially regulate the Rho GTPases at many levels, as shown by the 
red arrows. (Adapted from Larsen M. et al. 2003 Nature) 
 
2.1. ‘Classically activated’ Rho GTPases (Rac1, Cdc42 and RhoA) 
 
Rac1 is known to regulate signaling pathways for cell proliferation, apoptosis and 
activation of immune cells. However, its major function is the organization of the actin 
cytoskeleton (adhesion and differentiation) and the lamellipodium.18, 27, 28 Activated Rac1 
triggers a broad list of downstream effectors including proteins from the Wiskot-Aldrich 
syndrome protein (WASP)-family verprolin-homologous protein (WAVE), mammalian 
Diaphanous (mDia) and p21-activated kinase (PAK), which are implicated in the major 
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functions described below (Figure 4). The fact that the Rac1-knockout is embryonic lethal 
and the Rac2-, Rac3- and RhoG-knockout are viable and do not have developmental 
defects demonstrates the importance of Rac1 relatively to the other members of the Rac 
subfamily.28   
 Cdc42 function (as the other Rho GTPases) is related with receptor-mediated signal 
transduction leading to induction of gene transcription, cell cycle progression, apoptosis, 
migration, chemotaxis, and cell fate determination. 18, 28, 29 However, the primordial 
function of the Cdc42 is the regulation of cell polarity and actin cytoskeleton resulting in 
the filipodium formation. When activated, Cdc42 signals through WASP, mDia, the insulin-
receptor substrate p53 (IRSp53) and PAK to perform its functions in actin polymerization 
(Figure 4).28, 29 Its function is thought to be essential during embryonic development as 
Cdc42-knockout mice that die at embryonic day 7.5.30 Recently, two spliced isoforms were 
described for Cdc42: the canonical isoform that is ubiquitously expressed and the brain 
specific isoform (further referred as Cdc42 Isoform 1 and Isoform 2 respectively).31 These 
isoforms differ only in their C-terminal exon, a region where they have a few amino acidic 
(a.a.) changes resulting in different lipidations of the proteins.32 Thus, both Cdc42 
Isoforms have a prenylation in that region, however Isoform 2 has an additional 
palmitoylation.31, 32 The palmitoylation of the Cdc42 Isoform 2 is essential for its 
membrane localization and in neurons plays a role in dendritic protrusion and dendritic 
spine formation.32 Additionally, the dual lipidation increases the affinity of Isoform 2 for the 
 
Figure 4. Cdc42 and Rac1 effectors in lamelipodia and filopodia pathways. Cdc42 induces actin 
polymerization by binding to WASP, or through IRSp53 Tyr kinase to induce branched actin filaments using 
the ARP2/3 complex. Rac activates the ARP2/3 complex through the WAVE complex. Cdc42 and Rac also 
induce actin polymerization by activation of mDia2. Rac- or Cdc42- mediated activation of the Ser/Thr kinase 
PAK phosphorylates, LIM kinase (LIMK), which phosphorylates and inhibits cofilin, thereby regulating actin-
filament turnover. In the neuronal growth cone, Cdc42 might result in reduced cofilin phosphorylation by an 
unknown mechanism (dotted line), thereby stimulating actin polymerization and filopodium formation. 
(Adapted from Heasman and Ridley 2008, Nature) 
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plasma membrane.33 Although its biologic function is poorly known, this specific feature of 
Cdc42 represents an additional mechanism of regulation, highlighting the fine-tuned 
activities of Rho GTPases. 
RhoA was the first identified member of Rho GTPases. Similar to Rac1 and Cdc42, RhoA 
transduces extracellular signals and, through it effectors, regulate cell migration, 
adhesion, survival, cell division, gene expression and vesicle trafficking in a cell-type 
dependent manner.18, 34 Rho has been postulated to be a major regulator of actomyosin 
and focal adhesion dynamics, but in several cell types, these effects are only seen in 
cooperation either with the other members of the Rho subfamily (RhoB and RhoC) or with 
its effectors (e.g. ROCKI/II (Rho-associated, coiled-coil containing protein kinase 1/2) or 
mDia) or with other Rho GTPases (Figure 5).34 In the past few years, several papers 
highlighted the important functions of Rho GTPases in regulating both the actin and 
microtubule cytoskeletons and the machinery involved in establishing polarity, during CNS 
and PNS development.  
Figure 5. RhoA effectors linked to actin reorganization. Rho via ROCK can stimulate myosin light chain 
(MLC) phosphorylation and together with mDia induces stress fibre formation. mDia is dependent on Src for its 
contribution to stress fibres and has also been reported to interact with IRSp53, which can mediate Arp2/3-
complex-induced actin polymerization. ROCK can also phosphorylate a number of other target proteins that 
may contribute to actin reorganization, including LIMK, which inhibits cofilin-mediated actin depolymerization. 
(Adapted from Ridley A.J. 2001, Journal of Cell Science) 
In the CNS neuronal development requires Rac1 and Cdc42 activity for neurite formation 
and outgrowth, as well as for axonal guidance.23, 26, 35 During axon polarization Cdc42 
activates Rac1 via the Par3/Par6 complex and Rac1 GEFs (Tiam1 or Tiam2/STEF), which 
are known to be essential to neuronal polarization and extension. This mechanism is a 
positive feedback loop between Rac1 and Cdc42, whereas the former could activate the 
latter through activation of PI3-kinase (phosphatidylinositol 3–kinase). In addition, Rac1 is 
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activated by GEF DOCK7 to allow the microtubule growth in the nascent axon. Neuronal 
differentiation progresses with axon extension and, for this is required an additional 
effector of Rac1 and Cdc42, the IQGAP3 (IQ motif containing GTPase activating protein) 
and, N-WASP (Neuronal- WASP) that is targeted only by Cdc42.23, 36 Nevertheless, Rac1 
functions are not restricted to the axon, and they also affect branching of the dendrites.35, 
37
 Regarding axon guidance, Rac1 and Cdc42 are associated with attractive cues and 
forward protrusion of growth-cone, while RhoA is associated with repulsive cues and 
growth-cone collapse. The RhoA and Rac1/Cdc42 are also thought to have antagonistic 
roles during axon formation and outgrowth.23, 34, 36 The functions of these Rho GTPases 
are not restricted to neurons, and it are equally important for the appropriate differentiation 
of OL and SC, even though through different mechanisms.24 Rac1-null SC lead to 
hypomyelination of the sciatic nerves and defects in radial sorting (similar to those seen 
on laminin or β1 integrin mutants). Rac1 activity, which is regulated by β1 integrin, is 
necessary for process extension and stabilization, and consequently for efficient radial 
sorting of axon bundles in a β1 integrin-dependent way.38 Recently two downstream 
effectors of Rac1 were described that directly influence myelination: NF2/merlin and 
cAMP.39 In the other hand, Cdc42, which activity is regulated by NRG1 affects SC 
proliferation and consequently radial sorting of axons (Figure 6).38 In OL, differentiation 
and the proper axon ensheatment and myelination depend on Rac1 and Cdc42 activity, 
and on RhoA inactivity.   
 
Figure 6. Regulation of SC and OL development by Rho GTPases.  A) Proposed mechanism for 
regulation of SC by Cdc42 and Rac1, which plays different but essential roles during SC development. Both 
Rac1 and Cdc42 are required for efficient radial sorting of axon bundles, a prerequisite for subsequent axon 
B A 
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myelination. B) Effects on OL differentiation upon expression of constitutive active (CA) or dominant negative 
(DN) Rho GTPases. Constitutively active Cdc42 and Rac1 and dominant negative RhoA induce outgrowth of 
OL, whereas dominant-negative Cdc42 and Rac1 or constitutive active RhoA inhibit OPC differentiation, when 
compared with the empty vector (EGFP). (Adapted from Benninger Y. et al. 2007, The Journal of Cell Biology 
and Liang X. et al. 2004, The Journal of Neuroscience) 
 
Similar to neurons, Rac1 and Cdc42 act synergistically in process extension and 
branching during the OL differentiation and myelination.38, 40 These two proteins are both 
necessary for proper axon ensheathing and their loss leads to the accumulation of a large 
amount of cytoplasm in the inner tongue of the process resulting in the formation of myelin 
outfoldings.40, 41 The Rho GTPase effectors participating in myelination are poorly known, 
however a few studies have shown that the Rac1 effector WAVE142 or the Fyn 
phosphatase, which affects RhoGAP p190 activity 41. This is in contrast with RhoA, which 
has a negative role in the OL differentiation inhibiting process extension. Although the 
molecular effectors of this regulation are not completely known, ROCK is thought to be 
one of them41.  
 
2.2. Atypical Rho GTPase RhoBTB2 
Rho BTBs are a group of atypical Rho GTPases that differ from the classical in their size; 
in their regulation by gene expression or protein stability and in the constitutive GTP-
bound state. They are much larger than classical Rho GTPases and have additional BTB 
domains, which are important for protein:protein interactions. Although the inactivation of 
RhoBTB genes did not reveal any associated phenotype, they are reported, in particular 
RhoBTB2, as tumour suppressor genes.21 As classical Rho GTPases, RhoBTBs are 
ubiquitously expressed in human, mouse and rat tissues. RhoBTB1 and 3 have higher 
expression levels then RhoBTB2. Albeit having lower mRNA levels, RhoBTB2 expression 
is significantly increased in the brain tissues, suggesting a tissue specific role.43 
 
3. Gene expression regulation 
 
The control of gene expression is a biological process essential to all organisms. Thus, 
gene expression requires an accurate regulation of several events during the 
development, division and differentiation of the cell. This regulation can be done at the 
transcriptional and co-transcriptional level or at the post-transcriptional levels. 
Transcriptional regulation occurs through the binding of regulatory proteins with specific 
DNA motifs, chromatin remodelling or by the interaction with the transcription machinery. 
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Regulation at the co-transcriptional level includes pre-mRNA processing: capping, splicing 
and polyadenylation. Post-transcriptional regulation comprises mRNA stability, transport, 
and translation mechanisms. Some of the key events that are regulated at the co-
transcriptional level are alternative splicing, polyadenylation (PA) and alternative 
polyadenylation (APA) and include several players cis- and trans-regulatory elements, 
RBP and small RNAs such as miRNAs. All of these mechanisms are emerging as key 
components in this regulatory process.44-46 
 
3.1. Co-transcriptional regulation 
 
Pre-mRNA (precursor mRNA) processing is a key step in mRNA maturation and in the 
specificity of several cellular programs such as tissue-specific gene expression, apoptosis, 
sex determination or development, implying a tight regulation of the mechanisms involved. 
The production of a mature and functional mRNA requires three well defined processing 
steps: (1) capping, that consists in the addition of a cap structure at the 5’end of the 
nascent transcript and prevents it from degradation; (2) splicing, involving the assemblage 
of small nuclear RNAs (snRNAs) with proteins in the small nuclear ribonucleic particles 
(snRNPs) to form the spliceossome, in order to remove the introns from the (pre-mRNA); 
(3) 3’end formation, that comprises the cleavage of pre-mRNA followed by the 
polymerization of an adenosine tail (polyA tail).47, 48 Through alternative splicing or PA, 
one single transcriptional unit can produce several mRNA molecules that could lead to 
different proteins or mRNAs with different 3’ UTR lengths. These fundamental processes 
occur co-transcriptionaly and, although being independent mechanisms, are in close 
crosstalk and interact with the transcription machinery.48, 49 
 
3.2. Polyadenylation 
 
The maturation of eukaryotic mRNAs requires a precise 3’end formation. As referred 
above this process comprises two steps, one specific endonucleolytic cleavage and the 
polymerization of the polyA tail by the polyA polymerase (PAP) (histone genes are the 
exception). This reaction is called polyadenylation (PA) and is driven by cis-elements 
present in pre-mRNA and trans-acting factors. The length of the polyA tail was recently 
described as organism-, development stage-, and tissue-specific and could vary between 
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30 to 100 nucleotides50, 51, in contrast with what was consensually accepted before (polyA 
tails with approximately 200 adenosines)44-46. The PA occurs in almost fully processed 
eukaryotic mRNAs48, and influence the stability, translation and transport of mRNA to the 
cytoplasm44, 46. However recent studies have, in part, challenged this view showing that 
the effect of the polyA tail on mRNA stability is restricted to the early developmental 
stages.50, 51 The consensus and stronger signal for PA (pAs) is the cis sequence AAUAAA 
(though the signal might be a weaker variant) that is recognized by the 3’end processing 
machinery, and normally is localized 10-35 nucleotides (nt) upstream of the cleavage and 
polyadenylation site (PAS).52 The cleavage and polyA tail addition occurs between this 
hexamer and an U/GU-rich downstream sequence element (DSE), which affects PA 
efficiency. Upstream U-rich sequence elements (USE) that present before the pAs could 
also affect the efficiency, providing binding sites for several protein factors.44-46 The core 
machinery responsible for cleavage and polyadenylation comprises four main protein 
complexes: cleavage and polyadenylation specificity factor (CPSF), that identify pAs and 
catalyse the cleavage reaction; cleavage stimulation factor (CstF), that recognize the 
DSE; and cleavage factor I (CF Im) and II (CF IIm), which are important for the assembly of 
the other members of the protein complex. For correct 3’end processing the core 
machinery have to engage 25 protein factors and around 60 individual proteins such as 
symplekin, PAP or polyA binding protein (PABP) (Figure 7).53, 54 This assemblage requires 
a fine-tune regulation to allow the accurate mRNA maturation.48, 53 The impairment of one 
of these factors or functions leads to a PA defect, related with a wide range of diseases or 
cellular conditions.55 
 
Figure 7. Core pre-mRNA 3’end processing machinery involved in cleavage and polyadenylation. The 
cleavage factors CF Im, CF IIm bind to their cis regulatory elements, USE, and CPSF binds to the pAs, 
whereas CstF binds to the U/GU-rich region, DSE. PAP polymerizes the polyA tail and PABP binds along the 
polyA tail.  (Adapted from Elkon R. et al. 2013, Nature) 
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3.3. Alternative polyadenylation 
 
In the human genome 70% of the genes have multiple pAs in their 3’ untranslated regions 
(3’UTRs), and in mammalian, 80% of the genes undergo APA.56, 57 APA controls gene 
expression by production of alternative mRNA isoforms due to the usage of different pAs 
present in one gene. Usage of one PAS over another is often attributed to the relative 
strength of the cis and trans-acting elements and to a close relation with transcription as 
mentioned above. The different types of APA differ in the localization of pA signal (intronic 
or exonic), which generates either different mRNA coding sequences (resulting in different 
proteins produced), or mRNAs with 3’UTRs of different lengths (Figure 8).44, 46, 58 
In the past few years, with the increase usage of genome wide methodologies, APA has 
been related with global physiologic events. Recent studies associate the usage of the 
shortest 3’UTRs with proliferation and transformation of the cells. The usage of proximal 
pAs is observed during the activation of T lymphocytes, cell proliferation and in cancer cell 
lines. Usage of proximal pAs has been related to the production of higher amounts of 
protein, due to the loss of regulatory elements, present in the longest 3’UTRs, such as 
target sites for miRNAs.59, 60 On the other hand the longest 3’UTRs are present 
preferentially in differentiation and development programs.  
Several studies have shown that different cell types were reprogrammed to generate 
induced pluripotent stem cells through APA modulation61, additionally 3’UTR lengthening 
was seen in the mouse embryonic development studies62. In addition, various works using 
RNA sequencing (RNA-seq) have shown that in brain tissues, both from Drosophila and 
Figure 8. Alternative cleavage and polyadenylation sites (PAS). A) Alternative polyadenylation (APA) in the 
3’ most exon. A hypothetical gene is shown, with two pAs located in the 3’UTR originating two mRNAs with 
different 3’UTR lengths. B) APA in upstream regions producing mRNAs containing different coding regions, 
and consequently, different proteins (Adapted from Tian B. and Manley J.L. 2013, Trends in Biochemical 
Sciences ) 
A 
 
B 
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mammalian models, there is a diffuse and extensive lengthening of the 3’UTRs. Curiously 
was found that brain 3’UTR extensions are significantly longer than previously 
annotated.63, 64 Alternative mRNA isoforms (resulting from APA) with longer 3’UTRs have 
more cis-regulatory elements in pre-mRNA such as binding sites for RBPs (involved in 
mRNA stability, localization and translation), miRNAs (involved in mRNA translation 
inhibition, cleavage/degradation), and regions with AU-rich content (important for PA site 
definition). Consequently, the differential signals usage implies that these RNA sequence 
elements will be differential used, affecting the transcript produced and ultimately 
modulating gene expression, both in a negative or positive manner. Therefore the 
differential selection of pAs in APA is a co-transcriptional mechanism that allows the 
mature mRNA present alternative places for regulation (Figure 9). 44, 46, 58 65 
 
3.4. RNA Binding Proteins 
 
The RBPs are key regulators of gene expression both at co- and post-transcriptional 
levels. The pre-mRNA processing is intrinsically related with the binding of RBPs to the 
specific sequences present in the mRNA resulting in the formation of messenger 
ribonucleoprotein particles (mRNP) complex. This interaction occurs trough the specific 
RNA-binding domains (RBD) in the RBP, which could be repeats of the same type or a 
conjugation of different domains. Together, the high variability of these RBD, the 
alternative splicing of RBPs pre-mRNA, the auxiliary functional domains, and the high 
diversity of RNA-binding sequences leads to a variety of mechanisms of regulation by 
RBPs in one cell.65 The importance of the RBPs is denoted by the high evolutionary 
conservation of their binding sequences.66 In short, cells are able to generate diverse 
mRNPs specific for each mRNA. Several aspects of the RNA biology such as 
transcription, pre-mRNA splicing, PA/APA, modification, export, localization, translation 
and turnover can be affected by RBPs. An efficient PA is dependent on specific RBPs, 
while one of the major players, the CPSF, binds to the pre-mRNA by its RNA-binding 
subunits. Poly(A) binding protein, nuclear 1 (PABPN1) is another important RBP for PA, 
that additional to CPSF, its binding promote the activity of PAP. 65 The impairment of 
RBPs biology, as mutations or alterations in their relative concentrations in the cell can 
lead to severe disorders.55 In other way, APA per se is able to escape or induce the 
regulation through RBPs according to the production of the shortest or longest mRNA 
isoforms respectively. Therefore, cells can use this mechanism, in addition to the 
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expression of cell-specific RBPs to achieve their cellular fate.62, 67 The usage of this type 
of regulation is most evident and known in neuronal development and specification, where 
the couple between the 3’ lengthening64, 68 and the expression of brain-specific RBPs such 
as ELAVl/Hu (ELAV Like RNA Binding Protein) proteins or NOVA (neuro-oncological 
ventral antigen)69 occurs. Another important feature of the neuronal cells involving RNPs 
is the mRNA transport and the local translation. As described above neurons extend long 
axons that need the transport of mRNAs to the apical zone for local translation of proteins 
in a rapid response manner.69, 70 The deregulation of these processes is one of the major 
causes of neuronal diseases.55 Although less is known, some studies have demonstrated 
the fundamental role of RBPs in OL differentiation and myelination. The quaking (QK) 
family of RBPs has identified in glial progenitors and OLs, where the differential 
expression of spliced isoforms coincides with the development of OLs and the onset of 
myelination. Mutation on qk gene leads to a failure in the development of mature 
myelinating OLs.71 Another important family of RBPs is the Musashi (Msi) family, which is 
preferential expressed in CNS stem cells, and its downregulation is required to the 
differentiation of OLs.72 Similar to neurons, in OLs the transport and local translation of 
specific mRNAs is also observed. The best studied is the myelin basic protein (Mbp) 
mRNA, which requires the formation of a RNP complex, where different family members 
of the RBPs hnRNP (heterogeneous nuclear ribonucleoprotein) play different functions 
through binding to the 3’UTR.73-75 This co-transcriptional regulation by RBPs is tightly 
associated with those of miRNAs, indeed recent studies have confirmed either 
competition or collaboration between them.76, 77 
 
3.5. MicroRNAs 
 
miRNAs are a class of nonconding RNAs with approximately 21 nucleotides in length that 
are able to post-transcriptionally silence mRNAs by binding to them through 
complementary or semi-complementary sequences. In mammals, the activity of 
approximately 50% of protein-coding genes is controlled by miRNAs. Although a single 
miRNA is often predicted to target several individual transcripts, their expression can 
impact the definition of the cell-specific protein profile, since miRNAs are expressed in a 
tissue-specific and/or developmental-stage-specific manner. The mRNA target sequences 
for miRNAs could be also binding sites for other miRNAs as well for RBPs, which give a 
multiple combinations for regulatory effects.76 In short, the biogenesis of miRNAs, initiate 
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with the formation of the pre-miRNA (precursor miRNA), which start by the transcription of 
an independent gene or an intron of one protein-coding gene by RNA polymerase II. This 
pre-miRNA is processed first by Drosha (in the nucleus) and by Dicer (in the cytoplasm) 
enzymes resulting in a ~20bp miRNA/miRNA duplex. This duplex is then separated and 
one of the strands becomes the mature miRNA that is incorporated into miRNA-induced 
silencing complex (miRISC). In miRISC, miRNAs will induce the translational repression 
or degradation, through the action of Argonaute (AGO) proteins and glycine-tryptophan 
protein of 182kDa (GW182), of the target mRNA.78, 79 The major determinant of the AGO 
action is a 6-8 nucleotidic domain at the 5’ end of the miRNA (this domain is called seed 
region). The seed region binds to the complementary region (‘seed matches’) on target 
mRNA and causes a decrease in its expression. The repressive effect is highest when the 
seed matches occur in the 3’UTR.80  
Regulation by miRNA activity has some of the most interesting examples in neurons, 
where miRNAs have a role in the regulation of localized protein expression. Thereby, the 
mRNAs can be inactivated by miRNAs to reach the dendritic spines, where it becomes 
accessible to the translation machinery, and also they can be downregulated in the 
dendritic spines by the local expression of specific miRNAs.78 In addition, neuronal 
determination and development are also dependent on miRNA activity, either through 
promoting the differentiation of the neural stem cells and progenitors (e.g. miR-124 and 
miR-9) or inducing their proliferation (e.g. miR-134, miR-25 or miR-137), according to the 
cluster of genes that are targeted.4 Another important role of the miRNA function in the 
CNS is the control of the production, differentiation and health of myelinating OLs. Specific 
miRNAs act in OPCs and in OLs through: (1) promoting OPC expansion; (2) suppressing 
OPC-expressed genes to promote differentiation; (3) the overall suppressing of 
inappropriate non-OL lineage gene expression in OPCs and OLs; and (4) by suppressing 
transiently genes required at high levels during myelin sheath formation. Several 
members of the miR-17-92 cluster have been described as necessary and sufficient for 
OPC proliferation.81 The two most highly induced miRNAs in differentiating OLs are miR-
219 and miR-338; they promote normal OPC differentiation into OLs.82 Recently, in one 
study it was shown that myelination of the CNS is promoted by the expression of miR-
23a.83 Thus several steps of development and differentiation of CNS can be regulated 
either through inducing or repressing miRNAs. The impairment of these functions by the 
loss of miRNA target sequences can lead to several disorders or cellular conditions55.  
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Figure 9. Regulation by cis- and trans-acting elements in the 3’ UTR originated by APA. Two mRNA 
isoforms are shown containing different RBPs binding sites and miRNA target sites. Their impact on mRNA 
localization, translation and degradation are indicated. CDS, coding sequence. (Tian B. and Manley J.L. 2013, 
Trends in Biochemical Sciences) 
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Aims 
 
In this thesis we addressed three main aims: 
 
Part I 
• Characterization of Rho GTPases APA during OL differentiation. 
• Understand if the mechanism of Rho GTPases APA is cell type specific. 
 
Part II  
•  Study the function of Cdc42 Iso1 and Cdc42 Iso2 in OL differentiation. 
   
  
  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
MATERIAL & METHODS 
  
  
MATERIAL & METHODS 
Page 23 of 92 
In silico analysis 
The UCSC genome browser was accessed to check for APA sites of mRNAs. The 
nucleotide sequences were obtained from NCBI database. Conservation of nucleotide 
sequences among different species was performed using the Geneious v4.8 software84. 
To predict putative binding sites of RBPs, the PBSFinder85 (tool developed by us), 
RBPDB86 and SFmap databases87 were used; while for microRNAs predition, the 
microRNA.org88, mirWalk 2.0 database89 and Targetscan.org were used. 
 
Cell Culture 
Primary mixed glial cultures. Primary mixed glial cultures (composed of OPC, microglia 
and astrocytes) were harvested from post-natal day (P) 1 to P2 neonatal Wistar rat cortex 
following a standard protocol90 with minor modifications91. In brief, dissociated rat neonatal 
cortices were cultured at 37 °C in 7.5 % CO2 in DMEM with 10 % FCS and 
penicillin/streptomycin for 10 days in vitro.  
Microglia. To remove the microglia on the top of the mixed glial cultures, the flasks were 
shaken for 1 h at 200 rpm on an orbital shaker. Microglia were plated at 1 x 106 cells per 
ml into 10 cm plate in DMEM/F12 supplemented with 1 ng/ml GM-CSF and 10% FBS 
media. The cells were left 24 h for recover and adhesion, and were used directly for total 
RNA extraction.  
Oligodendrocytes. After shaker to remove microglia, mixed glial cultures were shaken at 
240 rpm overnight to dislodge the loosely attached OPC. These OPC were further purified 
from contaminating microglia by a differential adhesion step. Purified OPC were plated at 
a density of 20,000 cells per 0.8 cm2 well in proliferation media (SATO media [L-glutamine 
(4 mM), putrescine (16 µg/ml), T4 (400 µg/ml), T3 (400 µg/ml), progesterone (6.2 ng/ml), 
sodium selenite (5 ng/ml), BSA V (100 µg/ml), insulin (5 µg/ml), holo-transferrin (50 
µg/ml)] supplemented with PDGF-A (10 ng/ml), FGF-2 (10 ng/ml), 1 % penicillin/ 
streptomycin). After 2 days the cells are harvested, for day 0 time point, or maintained for 
induction of differentiation. The proliferation media was replaced with differentiation media 
(SATO media supplemented with1 % penicillin/ streptomycin and 0.5 % FCS). Cells are 
collected at 3, 5 or 7 days of differentiation. All cells were cultured in Poly-D-Lysin and 
Laminin coated plates. All mixed glial cultures were maintained until a total of three 
shakes were performed. 
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Astrocytes. Upon the three shakers describe above, the mixed glial cultures were subject 
to trypsinization and plated in new flask for further astrocyte purification. A total of three 
steps of purification were performed. After obtaining a pure astrocytes culture, the cells 
were used directly for total RNA extraction.  
Neurons. High density cultures of rat cortex, hippocampal and striatal neurons were 
prepared from E18–E19 Wistar rat embryos as previously described92, and were obtained 
from Teresa Summavielle’s laboratory. Briefly, neuronal cultures were maintained in 
serum-free Neurobasal medium (Gibco Invitrogen), supplemented with B27 (GibcoInvitro- 
gen), glutamate (25 µM), glutamine (0.5 mM) and gentamycin (0.12 mg/ml). Cells were 
cultured at a density of 9 × 104 cells/cm2 on poly-D-lysine coated 6-well microplates, and 
kept at 37 °C in a humidified incubator with 5% CO2/95% air, for 24 h, 7 or 14 days in vitro 
(DIV), and were used directly for total RNA extraction. 
Optic and sciatic nerves. Optic and sciatic nerves were harvested from P2, P14 and P30 
Wistar rats followed by a rapid freeze at -80ºC. The tissues were homogenized in TRIzol 
(Invitrogen) reagent before proceeding to the total RNA extraction. 
 
RNA extraction 
Total RNA was extracted with TRIzol (Invitrogen) reagent following the standard protocol. 
The cells were incubated 5min at RT with 1 mL of TRIzol and then overnight at -80ºC. To 
separate the RNA fraction chloroform was added to the lysates, mixed and centrifuge for 
15 min at 11400 rpm at 4ºC. The aqueous phase was transferred to a fresh tube, where 
Glicoblue (15 mg/mL, Ambion Life Technologies) and the same volume as the aqueous 
phase of Isopropanol was added and mixed. The samples were frozen overnight at -80ºC 
and after, centrifuged twice, 20 min and 10 min at 11400 rpm at 4ºC, with a washing step 
with 75% cold ethanol between centrifugations. The pellet was air dried and resuspended 
in Nuclease-free water (Thermo Scientific). RNA quantification was performed in a 
NanoDropTM 1000 Spectrophotometer (Thermo Scientific) and the RNA stored at -80ºC.  
The extraction of RNA enriched with small RNAs was performed using mirVanaTM 
isolation kit (Ambion, Life Technologies) and following the manufacturer’s protocol. Briefly, 
the cells were counted and 102 to 107 cells were pelleted and washed in cold PBS (1x). 
Cells were lysed in the lysis/binding buffer and incubated with miRNA Homogenate 
Additive provided in the kit. For RNA fraction extraction were added one volume of Acid-
Phenol:Chloroform and centrifuged. The aqueous phase was recovered into a fresh tube 
and 1.25 volumes of 100% ethanol were added and mixed. This mixture was passed 
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through a filter cartridge before a wash step with miRNA Wash Solution 1. At this point 
was preformed the DNAse (DNase I recombinant, RNase free, 10 U/µL, Roche) treatment 
on column for 15 min.  Samples were washed again with miRNA Wash Solution 1 and 
twice with mRNA Wash Solution 2/3. After discard the flow-through, RNA was eluted in 
95ºC pre-heated Elution Solution. RNA quantification and storage was performed as 
described previously.  
 
Reverse transcription 
DNase treatment. To avoid DNA contamination, the total RNA was treated with DNase 
(DNase I recombinant, RNase free, 10 U/µL, Roche) in DNase I Incubation Buffer and 
Nuclease-free water (Thermo Scientific), for 1h-1,5h at 37ºC. The incubation was followed 
for 10 min at 75ºCfor enzyme denaturation. 
Reverse transcription reaction. cDNA was prepared using SuperScript IIITM Reverse 
Transcriptase enzyme (Invitrogen, Life Technologies) and 500ng of total RNA following 
the manufacture’s guidelines. Briefly, the RNA was denatured for 5 min at 65ºC with 
dNTPs (10 mM), Random Hexamers (50 mM) and Nuclease-free water (Thermo 
Scientific), followed for 5 min at 4ºC. The mixture for reverse transcription was prepared 
with the cDNA synthesis buffer (5X), DTT (0,1 M), RiboLock RNase Inhibitor (Thermo 
scientific) and SuperScript III RT (200 units/µL, Invitrogen) reverse transcriptase enzyme, 
added to the denaturated RNA samples and gently mixed. The samples were then 
incubated for 10 min at 25ºC, 60 min at 50ºC and 10 min at 70ºC to inactivate the 
enzyme. For discard genomic DNA contaminations, negative reactions were performed 
without SuperScript III.  
 
RACE (Rapid Amplification of cDNA Ends) 
Reverse transcription reaction. The cDNA synthesis was performed using the 
SMARTerTM RACE cDNA Amplification kit (Clontech) following the manufacturer’s 
protocol, shortly described here. Initially, the RNA and 3’-CDS Primer A were added to 
sterile water. The samples were incubated at 72ºC for 3 min, cooled at 42ºC for 2 min and 
then briefly centrifuged. During the incubation step were prepared the Master Mix with 
Buffer Mix for 3’RACE-Ready cDNA synthesis (5x First-Strand Buffer, DTT (20mM) and 
dNTP Mix (10 mM)), RNases Inhibitor (40 U/µL) and SMARTSribeTM Reverse 
Transcriptase (100 U). This Master Mix were added to the denaturated RNA samples and 
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incubated at 42ºC for 90 min and at 70ºC for 10 min. Finally the first-strand reaction 
products were diluted in 20-250 µL of Tricine-EDTA Buffer and stored at -20ºC. 
3’RACE. The PCR reactions were performed also with SMARTerTM RACE cDNA 
Amplification kit (Clontech) by preparing, for each PCR reaction, an Master Mix with PCR-
Grade Water, 10x Advantage 2 PCR Buffer and dNTP Mix(10 mM) that were added to the 
3’-RACE-Ready cDNA (previously prepared), UPM (universal primer mix) (10x) and GSP 
(gene specific primer) (10 mM) (Table 1). Negative control reactions were performed 
using only one primer of the primer pair, UPM or GSP primer. The samples were 
submitted to a thermal cycles starting at 98ºC for 2 min followed for 5 cycles at 98ºC for 
30 sec and at 72ºC for 3 min and, 5 cycles again at 98ºC for 30 sec, 70ºC for 30 sec and 
72ºC for 3 min and finally, 25-27 cycles at 98ºC for 30 sec, 68ºC for 30 sec and at 72ºC 
for 3 min with an final extension at 72ºC for 7 min. The 3’UTR-enriched cDNA were stored 
at -20ºC.  
Nested PCR. For nested PCR were added 5x Phusion HF Buffer (Thermo Scientific), 
dNTPs (10 mM), GSP, NUP, Phusion High-Fidelity DNA Polymerase (2 U/µL, Thermo 
scientific) and Nuclease-free water (Thermo Scientific) to the 3’UTR-enriched cDNA 
resulting from 3’RACE. The samples undergoes thermal cycling starting at 98ºC for 1 min 
to activate the enzyme, followed by 25-27 cycles at 98ºC for 10 sec, 65ºC for 30 sec and 
72ºC for 2 min and the final extinction at 72ºC for 7 min and cooling to 4ºC.  
 
Table 1. Sequence of primers used in 3’RACE reactions. 
Target Primer pair Sequence 5’->3’ 
Rat Rac1 Rac1_4 F CTCCCATTACCTACCCGCAGGGGCTAGC 
Rat RhoA RhoA F GCTCTGCAAGCTAGACGCGGGAAG 
Rat Cdc42 Isoform1 Cdc42_Iso1 F GAACCGAAGAAGAGCCGCAGGTGTG 
Rat Cdc42 Isoform2 Cdc42_Iso2 F CCGTTTTCTCCTTCCCCCCTTTGCTGC 
 
Cloning into TOPO® vector 
DNA extracted from the gel bans (produced by the 3’RACE reaction) was prepared for 
TOPO® TA Clonning Reaction (Invitrogen, Life technologies). First, dATPs were added to 
the purified DNA in a mixture of 4 µL DNA, 0,25 µL dATPs (10 mM), 0,8 µL GoTaq Buffer 
(5X) (Promega), and 0,1 µL GoTaq® DNA Polymerase (Promega). This reaction was 
performed at 72ºC for 15 min. Cloning was done by adding 4 µL  of DNA from the 
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previous reaction and 1 µL salt solution to 1 µL vector, and   incubating these mixture for 
30 min at RT.  
Transformation of competent bacteria 
For transformation 6 µL of the TOPO-clonning reaction were added to 100 µL of chemical 
competent cells. Cells were incubated for 15min in ice following a heat shock at 42ºC for 1 
min and put back 5 min on ice. 400 µL of LB medium were added and the cells incubated 
at 37ºC for 45-60 min in an orbital shaker. Transformed cells were than centrifuge and the 
resuspended pellet was plated and grown in LB plates with Ampicilin (in 1:100 ratio), 
overnight at 37ºC. 
 
Colony PCR 
The colonies from de previous plates were submitted to colony PCR. The reaction 
consisted in 0,15 µL of GoTaq® DNA Polymerase, 2 µL Green GoTaq® Reaction Buffer 
(1X) (Promega), 0,75 µL MgCl2 (25 mM) (Promega), 0,5 µL M13 forward 
(AGCATCAAATGGCGTGAGA) and reverse (AGCATCAAATGGCGTGGAGA) primers 
(10 mM), 0,5 µL dNTPs (10 mM) mix and ddH2O up to 10 µL. With a sterile tip, the 
selected colony is dipped into the PCR tube and subsequently used to inoculate new 
ampicilin LB plates, and incubated at 37 ºC overnight. The positive colonies are selected 
and inoculated in liquid LB medium. Plasmid DNA was extracted from the suspension 
cultures using the PureLink® Quick Plasmid Miniprep Kit (Invitrogen), following the 
manufacturer’s protocol, and samples were sequenced outside the lab. 
 
Real-Time qPCR 
For mRNA expression quantification, the primer pairs efficiency was optimized initially and 
secondly was performed the quantification itself. Briefly, a standard curve with serial 
dilutions of cDNA (undiluted, 10- or 100-fold diluted) was added to each primer pair (10 
pmol) (Table 3), the SYBR® Select Master Mix (Applied biosystems, Life technologies), 
Nuclease-free water (Thermo Scientific) to a final volume of 10 µL. Reactions were 
incubated in the StepOne Real-time PCR System (Applied Biosystems) thermocycler 
following the program recommended by the company (50ºC for 2 min, 95ºC for 2 min and, 
40 cycles at 95ºC for 15 sec and 60ºC for 1 min). The annealing temperature was 
adjusted to 58ºC in order to obtain more efficiency for some primer pairs. For an ideal 
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efficiency the slope of a standard curve generated with 10-fold dilutions would be -3.32. 
The slope obtained is used to calculate the primer pair efficiency using the formula E=10(-
1/slope)
 and the correspondent efficiency percentage was calculated by the formula % E= 
(E-1) x100). The primer pair was considered efficient between 90-110% of efficiency. To 
quantify the relative mRNA expression levels were used the guidelines described above, 
with minor modifications. The reactions were analysed using a method that generates the 
expression of the target gene (TG) relative to the reference gene (RG), the comparative 
CT method (2-(Ct(TG)-Ct(RG))), assuming the maximum efficiency, since the results do not 
suffer significant changes when using the real efficiencies. The reference genes used 
were Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) and tyrosine 3-
monooxygenase/tryptophan 5-monooxygenase activation protein, zeta (YWHAZ) that 
were described as good housekeeping genes for the working models93, 94. These 
expression levels were also used to generate ratios between the longer isoforms and the 
total mRNA levels and, to normalize the expression of a specific sample relatively to a 
reference sample (e.g. day 7 of differentiation over day 0)95.  
 
MicroRNA expression quantification 
Reverse transcription. The microRNAs experiments were performed using the TaqMan® 
MicroRNA Assays (Life Technologies) protocol. Shortly, the RNA enriched with small 
RNAs was extracted as previously described, following by a reverse transcription reaction. 
For this reaction were mixed 10 mM dNTPs, RiboLock RNase Inhibitor (Thermo scientific), 
10x Reverse Transcription Buffer, MultiScribeTM Reverse Transcriptase (50 U/µL) (Applied 
biosystems, Life Technologies), and Nuclease-free water (Thermo Scientific) with 1-10 ng 
of RNA and 5x RT primer (Table 2). The mixture was incubate on ice for 5 min before 
proceed to the thermal cycling that was started at 16ºC for 30 min, heated at 42ºC for 30 
min and then at 85ºC for 5 min and finally cooled at 4ºC.  
Real-time qPCR. For expression quantification of microRNAs was prepared a master mix 
for each probe, containing TaqMan® Universal PCR Marter Mix II no UNG and TaqMan® 
Small RNA Assay (20x) (Table 2) (Applied biosystems, Life Technologies), Nuclease-free 
water (Thermo Scientific), and reverse transcription product from the previous reaction. 
This reaction was transferred to the reaction plate, which was placed in the StepOne 
Real-time PCR System (Applied Biosystems) thermocycler using the recommended 
program (2 min at 50ºC; 10 min at 95ºC, and 40 cycles of 15 sec at 95ºC and 60 sec at 
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60ºC). The results were analysed with the previously described CT method using as 
reference gene the human U6 small nuclear RNA96. 
 
Table 2. References of Taqman Probes. 
Target Reference 
hsa-miR-195 000494 
mmu-miR-137 001129 
hsa-miR-92a 000431 
U6 snRNA 001973 
 
Actinomycin D treatment 
The transcription inhibition was performed adding an antineoplastic antibiotic, Actinomycin 
D (Sigma-Aldrich®) to the cultured cells. No previously studies describing the ideal 
concentration of Actinomycin D for OL were preformed, so we used the concentration of 
0,4mg/mL (an intermediate value between several cellular types). The chemical 
compound was added in that concentration to the culture media and the cells were 
collected after 10, 30, 60 and 90 min of exposure. The total RNA were extracted and 
converted in cDNA and gene expression analyse through RT-qPCR. The expression 
levels of the Actinomycin D samples were normalized to untreated samples that represent 
100% of mRNA expression in order to achieve the mRNA expression decay in treated 
samples. These values were compared with a previous described long non-coding 
RNA2700046G09Rik83 (Table 3) as a control.  
 
RNA immunoprecipitation 
RNA immunoprecipitation (RIP) was performed using the EZ-Magna RIP RNA-Binding 
Protein Immunoprecipitation Kit (Merck Millipore). 
Lysate preparation. Following the manufacturer’s guidelines, 8 x 106 to 11 x 106 OPCs 
were washed twice with ice-colded PBS and centrifuged at 1500 rpm for 5 min at 4ºC. The 
pellet was resuspended in complete RIP Lysis Buffer (RIP Lysis Buffer, Protease Inhibitor 
Cocktail and RNase Inhibitorfor each used antibody) and the lysate was incubated for 5 
min on ice before was stored at -80ºC. 
Preparation of magnetic beads for immunoprecipitation (IP). For each IP (protein of 
interest, positive and negative controls) magnetic beads were washed separately twice 
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with RIP Wash Buffer and incubated 30 min in rotation at RT with 5 µg of each antibody 
diluted in RIP Wash Buffer. The beads were then centrifuged and washed again as before 
and placed on ice. 
 
 
IP of RNA-binding Protein-RNA complexes. The previously prepared lysates were 
centrifuged at 14000 rpm for 10 min and, the supernatant was added to de magnetic 
beads resuspended in RIP IP Buffer (RIP Wash Buffer, 0,5M EDTA and RNase Inhibitor 
for each used antibody). At this time 10% of supernatant for Input (that will be used for 
generate the standard curve for comparison) was removed and stored at -80ºC. The 
samples were incubated in rotation overnight at 4ºC and briefly centrifuged then for 
remove the supernatant. Following 6 washes steps with RIP Wash Buffer were performed. 
Purification of RNA. The immunoprecipitated samples and the previously separated 
input were mixed to the Proteinase K Buffer (RIP Wash Buffer, 10% SDS and Proteinase 
K) before incubation with shaking at 55ºC for 30 min. The input and the immunoprecipitate 
supernatant were added to RIP Wash Buffer and phenol:chloroform:isoamyl alcohol and, 
centrifuged at 14000 rpm for 10 min at RT. The RNA extraction was performed as 
described previously with minor modifications specific of the EZ-Magna RIP kit.   
Analyses of immunoprecipitatedRNA. The RNA (up to 2 µg) was converted in cDNA 
and the relative occupancy of the immunoprecipitated protein at each RNA site was 
estimated as follows: 2Ct (input)-Ct (IP), where Ct (input) and Ct (IP) are mean threshold cycles 
(Ct) of quantitative RT-qPCR done in duplicate on RNA samples from input and specific 
immunoprecipitations, respectively. As negative control, IgG was used. 
 
Cell transfection 
The CG4 cell line (a cell line of rat central nervous system glial precursors) was 
transfected with GFP-cdc42prenyl and GFP-cdc42palm plasmids (Addgene) using 
Lipofectamine® 3000 Reagent (invitrogen, Life Technologies) and following the 
manufacturer‘s protocol. In brief, lipofectamine was diluted in Opti-MEM medium (Gilbco®, 
Life Technologies) and added in 1:1 ratio to a master mix containing the plasmidic DNA 
(0,5-5 µg/µL) and P3000 reagent (2 µL/µg DNA) also diluted in Opti-MEM. TheDNA-lipid 
complex were added to the cells (0,5x105 cells/well) at 70%-90% of confluence and 
incubatedfor 5 min at RT initially, and then for 2-4 days at 37°C before analysis by 
fluorescence microscopy. 
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Immunofluorescence (IF) 
For IF analyses, cells (plated over coverslips treated with Poly-D-Lysin and Laminin) were 
fixed with 4% PFA for 10 min, washed twice for 5 min with PBS (1x) and store at 4ºC. The 
cells were then permeabilized with 0,1% TX-100 for 5-15 min and washed twice with PBS 
(1x) for 5 min before the blocking step, which was performed by incubation with 10% NGS 
(Normal Goat Serum) in PBS (1x) for 30-60 min at RT, and probed with mouse mAb anti-
α-tubulin (T5168, Sigma), overnight at 4ºC in blocking solution. After 60 min at RT, in 
dark, Alexa Fluor 647-conjugated goat anti-mouse IgG (A21235, Molecular Probes) in 
blocking solution was used as secondary antibody. The incubations were followed by 3 
washes with PBS (1x) for 5 min each. 4´,6-Diamino-2-phenylindole hydrochloride (DAPI) 
(Molecular Probes) was used to detect nuclei.  The coverslips with the cells were mounted 
and analysed in Leica DMI 6000B microscope.  
 
Western-blot 
Whole-cell lysates were prepared adding RIPA buffer (150 mM sodium chloride, 1.0% 
Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris, pH 8.0) with 
phosphatase and protease inhibitors, directly to the cells and stored at -80ºC. The 
samples were then quantified (following the BSA standard curve protocol) and, the 
proteins were separated by SDS-PAGE using 5% (stacking gel with H2O, 30% Acrilamide 
Mix, 1,0 M Tris (pH 6,8), 20% SDS, 10% APS and 0,01% TEMED) and 12% (resolving gel 
with H2O, 30% Acrilamide Mix, 1,5 M Tris (pH 8,8), 20% SDS, 10% APS and 0,004% 
TEMED) of Polyacrilamide Gels. The loading buffer was added to the proteins in 1:1 
dilution and the mixture was run in running buffer (25 mM Tris-Cl, 192 mM glycine and 
0,1% SDS) for 1h30 min ( 30 min at 80V and 1h at 100V). The samples were transferred 
with the iBlot® Gel Transfer stacks Nitrocellulose, Mini kit in iBlot® gel transfer device (Life 
Technologies) to the nitrocellulose membrane. For blocking, the membrane was incubated 
in 10% of powder milk/PBS-T solution (8 mM disodium phosphate, 150 mM NaCl, 2 mM 
monopotassium phosphate, 3 mM KCl, 0.05% Tween® 20) during 1h at room 
temperature. This solution was replaced by a solution with primary antibody diluted in 5% 
powder milk/PBS-T solution and incubated overnight at 4ºC and followed by 3 washes 
with PBS-T of 5 min each. Finally, the membrane was incubated 1h with the appropriate 
secondary antibody in 5% of powder milk/PBS-T and washed again as before. All of the 
incubations were done in agitating platforms. Detection was performed using enhanced 
MATERIAL & METHODS 
Page 32 of 92 
luminescence (ECL Prime; Amersham/ GE Healthcare) solution in a ratio 1:1 of A and B 
reagents as recommended by the manufacturers.  
 
Antibodies 
A rabbit monoclonal Ab (mAb) anti-YBX1 (ab12141; Abcam) was used for RIP 
experiments. The mouse mAb anti-Rac1 (ab33186, Abcam) and mouse mAb anti-tubulin 
(T5168 Sigma) were use as primary antibody and goat-anti mouse peroxidase (115-035-
146, Jackson Immuno Res.) was used as secondary antibody for Western blot. 
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Table 3. Sequences of primers used in RT-qPCR. 
Target Primer pair Sequence 5’->3’ 
GAPDH 
GAPDH F TGGAGTCTACTGGCGTCTT 
GAPDH R TGTCATATTTCTCGTGGTTCA 
2700046G09Rik 
lncRNA F CCCTAGTTCAATTCCCAGCA 
lncRNA R TAACTCTTGCATGCCTGGTG 
Rat Rac1 
Rac1 F GAAGCTGACTCCCATTACCTACCC 
Rac1 R GGGACAGAGAACGGCTCGGATAG 
Rac1 pA2 F AACTGAATAAAAGTGTCACGGGT 
Rac1 pA2 R GAGACACTGATAAGATCGGC 
Rat RhoA RhoA F GACGGGAAGCAGGTAGAGTT 
RhoA R CGCCTTGTGTGCTCATCATT 
 RhoA pA2 F ACCCCAGACTAGATGTAGTATTTTT 
 RhoA pA2 R ACACTTTCTGTGGGAATGACA 
Rat Cdc42 Isoform1 Cdc42_Iso1 F GAGACTGCTGAAAAGCTGGC 
Cdc42_Iso1 R TCTTCTTCGGTTCTGGAGGC 
Cdc42_Iso1 pA2 F TCAGATTATTTTGTTTGCAAGTTCC 
Cdc42_Iso1 pA2 R AGATCAGGACTGGGGAAGGA 
Rat Cdc42 Isoform2 Cdc42_Iso2 F GAGACTGCTGAAAAGCTGGC 
Cdc42_Iso2 R CTCGAGGGCAGCTAGGATAG 
Cdc42_Iso2 pA2 F AAACAAAGGAATAAAACCATCCTGT 
Cdc42_Iso2 pA2 R GAGTTTGCTCTAAGGTGTTGAGT 
Rat RhoBTB2 
RhoBTB2 F TCCCTCGAGACATGAAGGCT 
RhoBTB2 R GCACGCTGATAGTGGTCCTC 
RhoBTB2 pA2 F  CATCGTCCCATGGGCTTACT 
RhoBTB2 pA2 R GCCTTGATGTGGGCTCTGAA 
Rat Pum2 
Pum2 F ACTACAATTCCCAACAGCAGC 
Pum2 R GAGCAAGGCCTGCTGAGAA 
Rat Nova1 
Nova1 F TTCCATCTCAACTTCCGCCC 
Nova1 R TCAGAGAGAGGCTGGACGAA 
Rat Ptbp1 
Ptbp1 F CGTCCCAGACATAGCAGTCG 
Ptbp1 R ATGATGAAGGGGCCGTTGCT 
Rat Ptbp2 
Ptbp2 F CACCTGTCCAACATCCCTCC 
Ptbp2 R AGCTTCTTCCACTGTTGCCAT 
Rat Elavl1 
Elavl1 F GCATCACCAGGCACAGAGAT 
Elavl1 R CGGGGACATTGACACCAGAA 
Rat Elval4 
Elavl4 F GCGTAAAGAGACTGATGTCTGGA 
Elavl4 R CCGTCAATGGTGATTGGGGA 
Rat Ybx1 
Ybx1 F GAAGGAGAAAAGGGTGCGGA 
Ybx1 R TGGTAATTGCGTGGAGGACC 
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1. Alternative Polyadenylation in Rho GTPases 
 
1.1. Rho GTPases produce two mRNA isoforms with different 3’UTR 
lengths due to the usage of two conserved pA sites 
APA is a mechanism that generates alternative mRNA isoforms allowing a differential 
expression of the same gene, which has been related to different cellular programs such 
as differentiation. During cell differentiation significant changes in the gene expression 
program occur. Since Rho GTPases are critical players in OLs differentiation and undergo 
alterations in it expression throughout this process, they are strong candidates to undergo 
APA. We started by identifying in silico putative PAS in the 3’UTR of human Rac1, Cdc42 
Iso1, Cdc42 Iso2 and RhoA using the UCSC Genome browser database 
(genome.ucsc.edu/). In this bioinformatics analysis we detected more than one PAS for all 
of the analysed human genes (Figure 10).   
 
 
Figure 10. Reported and predicted PAS for human Rac1, Cdc42 Iso1/2 and RhoA. The scheme represent 
the genomic sequence of the genes with the black boxes (Cdc42 Iso1 and RhoA) and blue boxes (Rac1 and 
Cdc42 Iso2) showing the exons, and the narrow boxes show the 3’UTRs. Both predicted and reported PAS 
are surrounded by orange rectangles. (Adapted from UCSC Genome Bioinformatics). 
Since in the genome browser the information about PAS for the rat genome is not 
available, the rat 3’UTRs were analysed to confirm the presence and the sequence of the 
putative pAs. In Rac1 3’UTR, that have 1709 base pairs (bp) in length, five putative pAs 
were confirmed; four of these are canonical signals and the second signal is a strong 
variant (ATTAAA) (Figure 12A). The 3’UTR of the Cdc42 Iso1 have 2251bp in length and 
also have five predicted pAs, however none is the canonical signal, four of them are the 
variant ATTAAA and one is a large sequence adenosines. This adenosine sequence is 
present also in humans and mouse, and is described as a strong pAs (Figure 12B)97. In 
the case of the Cdc42 Iso2 the 3’UTR is shorter (1358bp in length) than Cdc42 Iso1 and 
consequently only two putative pAs were detected, the first is the canonical AATAAA and 
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the second is the variant ATTAAA (Figure 12C). Finally, analysis of the RhoA 3’UTR, that 
have 1073bp in length, revealed the presence of three canonical pAs (Figure 12D).   
The presence of several putative pAs in the 3’UTRs of those genes does not mean that, 
all of the signals are used in a specific cell type or that they are used in the same manner 
or at the same time. However, as classical Rho GTPases possess diverse putative pAs, 
their expression during OL differentiation may be regulated by so far unexplored pre-
mRNA processing events such as APA. In order to evaluate if these genes could undergo 
APA during OL differentiation and to map their 3’ ends, 3’RACE analyses were performed 
(position of the RACE primers is depicted in Figure 11A). In these analyses, we used 
primary rat OPCs and the CG4 cell line differentiated in vitro for three days. The time point 
of three days was chosen because it is an intermediate stage where the cells are no 
longer proliferating but are not yet fully differentiated. Thus, probably the gene expression 
at this stage is a mixture of the two programs, which allow us the possibility to gain 
knowledge about all the mRNA isoforms produced in both conditions. The results of the 
3’RACE show that two mRNAs isoforms are produced by all of the tested genes (Figure 
11). The Rac1 3’RACE presented several bands (data not shown), but by performing a 
nested PCR, both the short and long mRNA isoforms of about 400bp and 1600bp 
respectively, were clearly visible (Figure 11B). The size of these isoforms corresponds to 
two of the previously described putative pAs. The usage of two pAs was also depicted in 
the nested PCR of Cdc42 Iso1 3’RACE reactions (Figure 11C). The shorter mRNA 
isoform have about 350bp and the longer mRNA isoform with nearly 1450bp and these 
sizes are in agreement with two of the predicted pAs found in Cdc42 Iso1 3’UTR. 
Interestingly, the 3’RACE for Cdc2 Iso2 mRNA showed different results according to the 
cells used, indicating that mechanisms governing APA depend on the type of cell (Figure 
11D). The nested PCR of the reaction in OLs samples revealed the usage of only the 
proximal pA, however in CG4 samples two isoforms were found, a shorter very faint band 
of about 200bp and an additional longer isoform, related with the distal pA, of about 
800bp. Finally, the RhoA 3’RACE reactions revealed two close isoforms (Figure 11E) of 
approximately 640bp and 760 bp. The band patterns were also confirmed in CG4, OLN93, 
rat and mouse Schwann cells (data not shown). 
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Figure 11. 3’RACE products using rat OLs and schematic representation of mRNA isoforms of Rho 
GTPases. A) Schematic representation of an mRNA showing the localization of the primers for the 3’RACE 
reactions. B-E) Representative experiment of the 3’RACE reaction. The first lane of the figures corresponds to 
the DNA ladder with the molecular weights in bp. The second lane shows the mRNA isoforms produced by OL 
at day 3 of in vitro differentiation. The schemes at the right represent both short and long mRNA isoforms with 
the indication of the pAs used. D) An additional lane with the results obtained using CG4 cell line is showed. 
A 
B 
C 
D 
E 
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To map the pAs and the cleavage site used for each pre-mRNA, the 3’RACE products 
were extracted from the gel, cloned into the TOPO vector and sequenced. The results 
showed that production of the short Rac1 mRNA isoform is due to the cleavage of pre-
mRNA at CA (red bar) that is preceded by two pAs (Figure 12A). The pAs used is 
certainly the ATTAAA signal (Rac1 pA1), because the spacing between this signal and the 
cleavage site, 15nt is the required for the reaction to occur, whereas the strongest 
canonical signal is localized too distant from the cleavage site. The longer mRNA isoform 
is produced by usage of the distal AATAAA signal (Rac1 pA2) (Figure 12A). Sequencing 
of Cdc42 Iso1 3’UTR revealed cleavage at CA, producing the shorter mRNA, however the 
pAs that used in this case is unclear. The 3’ UTR sequence have shown three 
noncanonical putative pAs upstream of the cleavage site, among which the adenosines 
stretch (Cdc42 Iso1 pA1) seems to be the best candidate as it is the strongest signal 
presented. This is in agreement with other observations97. Interestingly, downstream of 
the cleavage site there is long GU/U rich sequence that usually acts as a cleavage 
activatory element as it binds CstF. The long Cdc42 Iso1 mRNA isoform is produced by 
usage of the ATTAAA signal (Cdc42 Iso1 pA2) and the inefficient cleavage site GA 
(Figure 12B). Sequencing of Cdc42 Iso2 3’UTR showed that the two predicted pAs were 
used to produce the two confirmed mRNAs. The shorter mRNA is produced through the 
usage of the AATAAA signal and the cleavage site CA, whereas the longer mRNA isoform 
use the ATTAAA signal and it is also cleaved at an inefficient GT (Figure 12 C). As the 
longer mRNA isoforms of both Cdc42 Iso1 and Cdc42 Iso2 are produced by usage of 
inefficient cleavage sites, it is possible that other still unidentified activatory elements 
and/or factors are required for the selection of the respective pAs. RhoA 3’UTR 
sequencing revealed the usage of two very close canonical pAs, separated by only 118nt. 
Within this range of spacing between, these two pAs signals are in competition98, 99. The 
cleavage of the shorter and longer isoforms occurs at CA and TT respectively (Figure 
12D). Therefore, as both pAs are the canonical hexamer, both present DSEs, and the 
distal cleavage site is inefficient, other auxiliary elements must be involved in the distal 
pAs selection. Noteworthy, by visual inspection it is possible to identify a T-rich putative 
USE upstream the distal pA. These conserved regulatory elements activate mRNA 3’ end 
formation99, 100.  
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Figure 12. Mapping of the mRNA 3’ ends of Rac1, Cdc42 Iso1 and Cdc42 Iso2 and RhoA isoforms. A) 
Rac1, B) Cdc42 Iso1, C) Cdc42 Iso2 and D) RhoA mRNA 3’ end mapping by 3’RACE and sequencing. The 
pAs are shown in bold and colored in red and the cleavage sites are indicated by the red bar. Putative DSEs 
are underlined and putative pAs are shown in grey. 
To better characterize the pAs, the genome conservation of the 3’UTR of the selected 
Rho GTPases was evaluated. To that purpose, Rac1, Cdc42 Iso1 and Cdc42 Iso2, and 
Rac1 3’UTR 
 
ATGTCTGAGCCCCTCCCTCGGTCTTGGTCCCTGGAGCCTTTGTACGCTTTGCTCAGAAAATGGCGGAGTCTTCGCGTCTGATGCCAAGTTTT
TGTTACAGATTAATTTTTCCATAAAACCATTTTGAACCAATGAACCAGTCAGTAATTTTAAGGTTCTGTTTTAAATGTAAGAATTCCAACTTACA
GTCTATTAAAATTCAGCCCTAAAAC|ACAAAGCCTTCTTAAAGCCTTATTTTTCAAAATCCCCTATTCTTGCTCAGATTAAGAATTGCCAAAATA
CCTTGTGAACTAAGTTGCGTTGTGCTGAGAACATGTAAGCACTAAGCTGTTGAGAGACTTTGTCCTTAAGAAGACTGCAGCTTCTGGGCTCA
GGGGTGCAGACCCTCCCGTAGCTCCCAGACCGTGTGACACAGCACAGCCTCCTTAATGACACGCTGCCATGTAACGCACCTGTAACTTATC
AGCCCATGCTCATTACGTAACTTTGTACTGTACGTCACGATGGGTGTAACAGCTCTGCTCTTTGATTTCATAGTGAGTTCTCTAAAATACCAG
CTGACCGGCTTCTGCAGGCTTTGAACAGAACTCTGGCTCCTGTGTTGCCTCTAACGAAGTATTCTGTTCCTAGTCGTGGGTGTGCTGGGTGG
AGTGTGTGAAACACGACGTCATCAAAGGAGACAGACAGTATTTTGACTAATATGAAGTAGAGATTAATTTACACTACATTGTACATGGAGTAA
TTCAACTGAATAAAAGTGTCACGGGTAAAGCTTTTTAACGGTTAATTTCTGTCAAACAGTAGATGACAAATGGCCGATCTTATCAGTGTCTCTC
TTGAGCCCCCCTTCCCCCTGCTGTCCCTCCCCAGATGGGGCGTTGAGTCCATATTTAAACTGGCCATCCTCACAGTTGCTAACTTAGCAAGT
GCTTTTCTTTAGGACCCCCTTCTTAACGAGCAATATGTCTGACCTGTACTATAAGATCTTTCTGATAATGCATTCGGAGATTTTTTTGGTAGAT
AGTAGAAGTGCGTTCCTGTTTTCACCTTCCTTTACTCAGCTGACTAGTGCTTCCCTTCGTTTTCTAGTAACTGGGTGTAGAAATCACGTGCTG
CGGCTTTACAGTTTTTAAACTATTTTAGATATTCTGAAACATCACTGTCTTGCCAGAGTACCAACACTGTCATGTGATTGATGCCGCCCCCTCT
AGACCTCACCCACGCGGACACATGCTTCCCGTACCTTTGGGTCTGTGAGGTTCTGTCAAGCGCTAGTGCTAACGCCGTTCTGTACAACCTAA
CTCACTGGCAAGAACACAGTGTTGGGCCTTTCGACCACTAGAACAAACTTTTTTCAATTGACAGTTACAGAATTGTGGAGTGTTTTTACATTG
ATCTTTTGCTAATGCAGTTAGCAGTATGTTTTGCATGTATGACTTAATAAATCCTTGAATC|ATAAAA 
 
Cdc42 Iso1 3’UTR 
ACGCATCTCCAGAGCCCTTTCTGCACAGCTGGTGTTGTCATCATACTAAAAGCAATGTTTAAATCAAACTAAAGATTAAAAAAATTTAAAATTC
GTTTCTGCAATAATGACAGACGACCTGCACCTACCCACATGCACTCATGTGAGACAAGGCCCATTAGTATGGCCCCCTTGCCCTTCCGGTAA
TAGTTAATTTTGAATAATTATGTATTGTCTAAAAAGCGATGAGTGCTAGTTTTGTTTCCTTGTTTAAAAAAAAAAAAAAAAC|AACGCAAATCC
CCACAAACGTTTTGTTTTGTTTAAAAGCAAGGCATGCTTGTGCTGACTGTAACCGACTAATTCAGATCGTCAGAGCTGCTCCCTGGTCCATGT
GGAGAGTATTCTGGGGCATCTTAGTGTCTTCTGTTGTTTTGTTTTGTTTTTCTTCCACCCTTCTCTCCTTTTAGGGTGTGTATGGGGTTGTTTC
TTAGACTTGTATTTTAAAATTTGTAAACCTGAGGACAGCCTGTGGGGAGGAGGACAGATGATTTCCACATTCCACTCCCTAGGTCTAGTTTAG
CAACTGTGTCCCCACCTGGTGCTCTTAGGGAGGAGTGTGGGAATGCCTCGTTTAATAACGTACTCCTTCTTGAAAGCTGCCTTTTCTCTCCA
CCCTTAAGTGGACCCAGTCTTTGCTGAAACTCATGCAGGTGGGTGGGAGCTGTCTTGCCCCTCTCTAGGATGCACTCTACCTGTGACTGTGA
CTTTCAAGGGTATTTGTTTGCCATTTGCTGATTTGGGGGGGGGGGGATAACTTCTAACTTCTTTCATTGCTAAATGAAAAAAAGTATTGCACC
TTTTGAAATACACCAAATGGATTGAGTTCCTAATTAAAAGAGTTCTTTTGCCCCTGTCAGTCATTTTCTTATATGCTTAGCATAGATTTACAACT
CACTGTGTAGTGTTCCTAGATTCAGCTGAAGACGAGATACACAGGGTTCCTTAAGGGCTGGTGTTGGGAAACACAGCCGCACTGGTGATTG
CCATCTCCTTCAGGTGATGAGGTTACAGGCCTGCTTCATTAAGAAGCTATGAGCATGTGGGGTGGGGAGCATACTTTTAACCAACATGGGGA
CCAGTCAGGGCTGTACCCCTTTTTTTCTTCCATGCCTATGAGGAATCCTTGAACAACTGGCTGAAGCTCTCTCAAAAATGGCGAGAGATTCAT
GACTCTTTATAAGTGTTAATAGAGACTTTATCAGATTATTTTGTTTGCAAGTTCCAGTTTTTAAAAATGTTTAGGTAATCTCCTTCCCCAGTCCT
GATCTTGTAGATTCGTTAGTGCCGAACCAATGCTTTCTTGTGTCTCAACTCTTTGTATATGAATTCTTTTCAGATGTATTAAACAAACAAAACC
CTTCACAAGTG|AGCCTGAAGGTTGTTATTTTCCTCCGTCTCTTACTTTTCAGGTATTTAAAAGTGAGGATGTGACTCTTACATGACATCAACA
TCTAACAAATTTTGGTATAAAATTTTCAAGCTTTATTTTTGTCTTCTGACACTCCATATGCCTTCTCTCCTAAAATTGACAGCCAGCTCTGAAAC
TCCTCCCCTTGTATGCTGAGTAGGTCAGAGTAGTAAGTGCAGAAATGTGTGTGAAGACCTCACCTCCTGGAAGGCGGCACAAGCACACTCG
TGCAGAGCAGTGGGGCAGTAGACCACTTGCCTCAGCCTGCCTGCATTAAAG 
 
Cdc42 Iso2 3’UTR 
ACCGTTTTCTCCTTCCCCCCTTTGCTGCTGCTTCCTGTCCCACTACTGTAGAAAGATCATTTAAAACAAAGGAATAAAACCATCCTGTTTC|AA
AGCCTCTGCGTCTTCTTACTCAACACCTTAGAGCAAACTCTGTATTCATTTTTGATCATGAATGCAATTAGAATATTTTTGTGATCAGTAGTCAC
ATTAGACTTGTTTAACTTTCTGCTGCTTGAGTTGCCTGATGCTCAGAGCTTTTGGTTTGAATTATATTATTGCAAAAGGGAATGTGGTCTGGCA
TTAAGAATGATGTCTTCTTGGAGAAAATAAGAGTTTTAACACTTCTAGATGTTAGTTCTAGATGGAGAAAGTATCGCTAAACATCATTTTACTCT
TACTGATTGTTAATTGTAATTGCATGACAAACTATGAAAAGGGTTGACTTGATAGTAGAGTGTGACGGGGAAGGGAGGAGTCTCCTATGGTTT
TCCTGTGTGCAGTGAAACTTTTGTGTTGCTCTTGCTTTGGCTGTTGTGCTGTAGGTGGAGTGTTTGTCATTCTGGGATGGGGAAGGTGTCCA
TGTATCTGCTTACTGCTTTATGAGTTCATTGTTACACATTATCTCCTAATCCTAGCATCCATTTAACAATCGACTTAAGGTTTGCTGATGTTGAA
ATGTAAAGCTACTGCCTTTATATTCTCCTGCTTTCGATTCTATTGTTGTGAGGGAAACATACAGTTGTGGTTATCTTTACATTTTGAAATTAAAA
TTATACAATTGTTTG|TATAAATGCCTGGTGAAGC 
RhoA 3’UTR 
AGCCTTGTGACACGCAGCCTCATGCGGTTAATTTGAAGTGCTGTTTATTAATCTTAGTGTATGATTACTGGCCTTTTCATTTATCTATAATTTAC
CTAAGATTACAAATCAGAAGTCATCTTGCTACCAGTATTTAGAAGCCAACCATGATTATTAATGATGTCCAGCCTGTCTGACCAGCCAGGGTC
CTTCTGACACTGCTCTAACGCCCTCTCTGCACTCCACCTGACACCAGGCGCTCATTCAAAGAATTTCTTAACTTCCTGCTTCTTTCTAGAAAG
AGAAACAGTTGGTAACTTTTGTGAATTAGGCTGTAACTACTTTATAACTAACATGTCCTGCCTATTTTCTGTCAGCTGCGAGGAACTCTGGTGA
GTCACTACTTCAGAGCTTTACTCCTTAACAGATTCCATTGGCAGAGCTCTGGGGTGGGCACCCAGTGTTTGGAAACTTGATCAGCCAGAAAG
GCCCAAGTCCACGCAGCTGTGGCAGAGTTACAGTTCTGTGGTCTCATGTTAGTTACCTTATAGTTACTGTGTAATTAGTGCCACTTAATGTAT
GTTACCAAAAATAAATATATCTACCCC|AGACTAGATGTAGTATTTTTTGTATAATTGGATTTCCTAATTCTGATATTTGTCATTCCCACAGAAA
GTGTATTGCTTTTTTTTTTTTAAGAAAGTATTTGGAAATAAAGTCAGATGGAAAAT|TCATTTTTAAAATTCCCATTTTGTCACTTTCTCTGATAA
AATATGGCCATATCTCCCCTATTTAGCCCTATATATCATTCCAGTGCCCCTTTCCAGACTGGACTGAGGAAATAGGAATTGGTTTCATGCCTG
AGGCTGTTAGACTTTGGAGGTGGCATAGCCTTTCTCACCTGGACTGCAGGGCCTGGCTCTAAGTCACAGTGCTCCTTTCTCCACACTGTTAT
CCAAGTCGCCTCCCAGAGGAGCCACCAGTTCTTATGGGTGGCAATGGGTGGGTGGGTGGGGGGTCTCCTCTCTCCAGCTGACTAAACTTTT
TTCTGTACCAGTTAATTTTTCCAACTAATAGAATAAAGG 
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RhoA 3’ UTR sequences from rat, mouse and human were gathered from NCBI 
nucleotide database (ncbi.nlm.nih.gov/nuccore/) and aligned using Geneious v4.8 
software. Conservation of mammalian Rho GTPases is approximately 50%19, however the 
results of the conservation analysis revealed a surprisingly higher conservation of the 
3’UTR between the three species, with 100% pairwise identity value for the pAs 
sequences (Figure 13). These results showed for the 3’UTR an identity above 80% for 
Cdc42 Iso1 and Cdc42 Iso2, and RhoA, and over 76% in the case of Rac1. 
Although these analyses were performed with only three species, the high level of 
conservation indicates an important role for these sequences in regulating gene 
expression of Rho GTPases in these organisms. 
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Figure 13. Genomic alignment of Rho GTPases 3’UTR sequences (rat, mouse and human). 3’UTRs 
showing the high conservation throughout all sequence (showed by the darkness of the bars), with close-up 
on pAs (blue arrows). The conservation of the 3’UTR for A) Rac1, B) Cdc42 Iso1, C) Cdc42 Iso2 and D) 
RhoA. (Adapted from Geneious v4.8) 
D 
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1.2. Classical Rho GTPases preferentially use the proximal pAs 
during OL differentiation 
Previous genome wide studies have related the progressive lengthening of the 3’UTRs by 
APA in mammalian brain tissues64, as well as in developmental processes such as 
differentiation62. Additionally, it has been described that ubiquitously expressed genes that 
present alternative 3’UTRs, show a change in the isoforms ratio in response to 
transformation or differentiation programs.101 In order to investigate if APA have a role in 
Rho GTPases regulation during OL differentiation, the expression levels were analysed by 
RT-qPCR in cells at the OPC stage and in OLs differentiated in vitro for 3, 5 or 7 days. To 
measure the total expression of the mRNAs and the expression of the longest mRNAs 
isoform only, two specific primer pairs were designed as represented in Figure 14.  
 
Figure 14. Schematic representation of the primer pairs used in RT-qPCR analyses. A) Schematic pre-
mRNA sequence depicting the coding region, two pAs and respective cleavage sites at the 3’UTR. B) 
Hypothetic shorter mRNA isoform amplified by the primer pair spanning exon junctions. C) Hypothetic longer 
mRNA isoform will be amplified by the primer pair located in the coding region and also by the specific primer 
pair designed at the 3’UTR between the two pAs. 
As expected, the RT-qPCR results have shown variable expression levels of the genes 
during the OL differentiation (Figure 15A). Rac1 and RhoA increase its total expression 
during differentiation. Interestingly, the expression of Cdc42 isoforms show an opposite 
profile during differentiation, there is an increase in Cdc42 Iso1 total mRNA levels 
whereas Cdc42 Iso2 present a decrease from day 0 to day 7 (although the expression 
levels of Cdc42 Iso1 are 3 fold higher than those of Cdc42 Iso2). This suggests that 
A 
C 
B 
pA1 pA2 
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Cdc42 isoforms could have different roles in OL differentiation, i.e. Cdc42 Iso1 may have 
a particular importance in the differentiation process whereas Cdc42 Iso2 appear to be 
crucial for the proliferation stage (discussed in point 2 of this section). 
Figure 15. Relative mRNA expression levels quantified by RT-qPCR, of the different mRNA isoforms 
during OL differentiation. OLs were differentiated in vitro and at specific time points post differentiation, total 
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mRNA was collected. A) Total mRNA expression (CDS, colored in black), and the longest mRNA isoform 
expression (pA2, colored in white) was determined for each gene. B) The ratio of these expressions 
(pA2/CDS) was performed in order to obtain the variation of the pAs usage. Error bars show the standard 
deviation (SD) for at least three independent experiments. *p<0,05, **p<0,01. 
Confirming the results obtained from 3’RACE analysis, both mRNA isoforms are 
expressed, however, the expression levels of the longer mRNA isoforms are considerable 
lower than the total mRNA expression (Figure 15A). To understand how APA varies in the 
genes analyzed during OL differentiation, we determined the relative usages of one pAs 
over another: the ratio between the levels of pA2/CDS (Figure 15B). The alterations 
observed in pA2/CDS for Rac1, Cdc42 Iso1 and RhoA during OL differentiation were not 
statistically significant, and the proximal pAs is the most used for all these genes. In the 
case of the Cdc42 Iso2 the results show a significant increase in the ratio pA2/CDS, from 
day 0 to day 7. However these alterations do not reflect a preferential usage of the distal 
pA but they are due to the decrease in the total mRNA (and therefore, the ratio increases). 
In conclusion, we observed that classical Rho GTPases do not undergo an APA switch 
during OL in vitro differentiation and the proximal pAs is the most used.  
 
Rho GTPases act by integrating signals from the environment, therefore its expression 
and regulation may also be modulated by extracellular cues. Although the in vitro culture 
conditions try to reproduce as most as possible, the in vivo context, there are not all the 
signals derived from other cells, namely neurons. As our results were not in agreement 
with those that were previously published, which indicate a lengthening of the 3’UTR 
during cell differentiation and in brain tissues61, 62, 64, we decided to confirm this 
observation in vivo. For this proposes, we used mRNA extracted from the rat optic nerves 
(ON), which are mainly composed by OLs102. ONs were collected from the animals at P2, 
P14 and P30, which are the in vivo correspondents of the three defined stages of in vitro 
differentiation (d0, d3 and d5). The results showed that the relative mRNA expression in 
the ON is consistent with that observed in OLs. For Rac1 and Cdc42 Iso1 the total mRNA 
increase during the differentiation without significant changes in the long mRNA isoform 
expression, which is less expressed (Figure 16A-B). For Cdc42 Iso2, we observed an 
increase in the total expression at P14 (Figure 16A), which differs from that observed in 
vitro OLs, suggesting that in vivo Cdc42 Iso2 is expressed in a distinct manner. This 
difference could be due to the presence of signals, that not exist in culture, that regulate it 
expression or, less probable, by the influence of the small portion of axon present in the 
tissue. However, the expression of the longer mRNA isoform is in agreement with the OLs 
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results: its expression is almost null and the differences detected in the ratio pA2/CDS are 
due to the alterations in the total mRNA expression (Figure 16B).  
For RhoA the results indicate that the total mRNA levels increase with development. 
However the usage of the pAs compared to the in vitro OLs is different. At P2 the most 
used signal is pA2, but throughout differentiation the increase in the expression levels is 
mainly given by usage of the proximal signal. Therefore, for RhoA we observe a 
shortening in the 3’UTR during differentiation, which contrasts with previous results in 
mouse embryonic development and mammalian brain61, 62, 64.  
One hypothesis for the observed differences between ON and OL regarding RhoA 
expression, can be the presence of other cell types in the ON since ubiquitously 
expressed genes can use APA to achieve its tissue-specificity101. Although their relative 
small number (e.g. microglia or astrocytes), RhoA have distinct functions in different cell 
types. In astrocytes, as opposed to OLs and neurons, an increase in the activation of 
RhoA is necessary for cell body and process expansion103. On the other hand, preliminary 
results from João B. Relvas’s lab have showed a crucial function of RhoA in microglia 
activation (personal communication).  
Taken together our in vivo results are in agreements with our in vitro results for Rac1, 
Cdc42 Iso1 and Cdc42 Iso2. Furthermore, our results support the hypothesis that 
‘classically’ activated Rho GTPases do not use APA switch as a regulatory mechanism of 
gene expression during OL differentiation.  
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Figure 16. Relative mRNA expression levels of Rho GTPases mRNA isoforms during ON development. 
ONs from rats were collected at 2, 14 and 30 days post birth, and the total mRNA was extracted. A) The total 
and long mRNA expression was quantified for each gene by RT-qPCR.CDS (black bar), pA2 (grey bar). B) 
The expression ratio pA2/CDS was determined to obtain the variation of the pAs usage. Error bars show the 
standard deviation (SD) for at least three independent experiments. *p<0,05. 
 
It is possible that variations in the levels of the mRNA isoforms reflect different mRNA 
stabilities. Therefore, we decided to measure the mRNA half-life after actinomycin D 
treatment. Actinomycin D blocks transcription and therefore there is no synthesis of new 
mRNAs after the treatment. Thereby the mRNA decay can be accessed by quantification 
A B 
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of mRNA levels before and after the exposure to the chemical compound, at different time 
points. 
 
 
 
 
Rac1 mRNA t1/2(in min) 
 d0 d3 d5 
lncRNA 90 <30 <90 
CDS >90 >90 >90 
pA2 >90 >90 >90 
Cdc42 Iso1 mRNA t1/2(in min) 
 d0 d3 d5 
lncRNA 90 <30 <90 
CDS >90 >90 >90 
pA2 >90 90 >90 
A 
B 
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Figure 17. Stability of Rho GTPases mRNA isoforms. Stability of A) Rac1, B) Cdc42 Iso1, C) Cdc42 Iso2 
and D) RhoA mRNAs in OLs differentiated in vitro (at day 0, day 3 and day 5) was measured by RT-qPCR 
after 10, 30, 60 and 90 minutes of exposure to actinomycin D (time 0 corresponds to the untreated samples). 
The expression levels are normalized to the untreated samples. The tables resume the half-life of the mRNA 
isoforms. CDS (black line), pA2 (grey line). The long non coding RNA (red line) was used as a control. Error 
bars show the standard deviation (SD) for at least three independent experiments. Time in minutes. 
In this experiment we used OL differentiated in vitro at day 0, 3 and 5, and after 
Actinomycin D treatment we quantified mRNA levels at different time points: 0, 10, 30, 60, 
Cdc42 Iso2 mRNA t1/2(in min) 
 d0 d3 d5 
lncRNA 90 <30 <90 
CDS >90 >90 >90 
pA2 60 <30 60 
RhoA mRNA t1/2(in min) 
 d0 d3 d5 
lncRNA 90 <30 <90 
CDS >90 >90 >90 
pA2 90 >90 >90 
C 
D 
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90 minutes. As a control RNA we used lncRNA 2700046G09Rik that has been described 
as stable83. Of note, in the culture conditions used (with laminin) the lncRNA 
2700046G09Rik showed to be unstable. Our results show a high stability for both Rac1 
mRNA isoforms (Figure 17A) and RhoA (Figure 17D) in all stages of OL differentiation, 
with approximately 100% of expression levels even after 90 min. Analysis of Cdc42 Iso1 
mRNA decay showed also a similar stability for both total mRNA and long mRNA isoform 
with the exception of day 3, at which occurs the progressive decrease in the levels of the 
longer mRNA isoform (Figure 17B). This mRNA has an half-life of 90 min of treatment 
(Figure 17B) suggesting a mild instability of the longer 3’UTR at day 3. Figure 17C shows 
a higher decay of the long Cdc42 Iso2 mRNA isoform as opposed to total Cdc42 Iso2 
mRNA. Its half-life is reached at less than 30 min at day 3 and at 60 min of exposure in 
day 0 and day 5. These results are consistent with the expression levels suggesting that, 
in addition to the lower expression levels, the longer isoform derived from the pA2 signal 
usage is also more unstable. 
From these results it is possible to assume that for Rac1, Cdc42 Iso1 and RhoA, the lower 
expression of the pA2-derived mRNA isoforms is not due to its rapid degradation. On 
other hand, the lower expression of Cdc42 Iso2 longer mRNA may be due to its instability, 
possibly due to instability cis elements or miRNA target sites localized in the longer 3’UTR 
Taking all our results into account, it is reasonable to assume that the levels of the 
mRNAs quantified and represented in Figures 15 and 16 do not reflect instability of the 
longest 3’UTRs. This is in accordance with published results describing that regulation of 
the differential pAs usage is done through regulatory elements present in the 3’UTRs 
rather than through different degradation rates63, 101.   
In summary, we showed that classical Rho GTPases use the proximal pA signal during 
OL differentiation, in contrast with previous genome wide studies in the brain62-64 and thus 
we conclude that during OL differentiation most classical Rho GTPases do not undergo 
APA switch towards distal pAs, i.e. the preferential expression of Rho GTPases shortest 
3’UTRs could be related to a particular requirement for these proteins in OL differentiation. 
It was previously proposed for other genes that proximal pAs usage leads to an increase 
in the protein produced101 and the same mechanisms may also apply to Rho GTPases: 
use of the proximal pA site may avoid post-transcriptional down-regulation by miRNAs, for 
example. Therefore, one possible explanation for our findings resides in the nature of this 
family of proteins. As Rho GTPases are regulated at the protein level by cycling between 
activated and inactivated states, through GTP binding and release respectively, to perform 
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their functions, they may need to be highly expressed at the mRNA level and do not 
require another level of regulation (by APA). 
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1.3. Atypical RhoBTB2 mRNA expression during OLs differentiation 
RhoBTB2 is an atypical Rho GTPase that stays always in the active state and is not 
regulated at the protein level, suggesting that it may require another level of regulation, at 
the mRNA level, which may implicates a better regulation at the mRNA level.  
We therefore hypothesised that atypical Rho GTPases would undergo distal pAs selection 
during OL differentiation. Analysis of the RhoBTB2 3’UTR sequence have shown that it 
has 70,4% of pairwise identity, and three 100% conserved putative pAs (data not shown). 
However, by performing RT-qPCR with primer pairs for the coding region (CDS), for the 
region between the first and the second signal (pA2), and for the region between pA2 and 
pA3 (pA3), it was demonstrated that the pA3-derived isoform is not expressed (data not 
shown). Therefore we quantified total and pA2 RhoBTB2 mRNA levels at 0, 3, 5, 7 days of 
differentiation and found that there is always a preferential usage of pA2 during OLs 
differentiation (Figure 18A). The selection of the pAs is not affected, as the ratio between 
pA2-derived and total mRNAs do not change during the process (Figure 18B). The 
expression of the longest 3’UTR allows the differential binding of either RBPs or miRNAs 
and this could affect the RhoBTB2 expression levels, however, our results show that APA 
is not regulated during differentiation.  
 
 
 
Figure 18. Quantification of the relative mRNAs expression levels by RT-qPCR, of the different 
RhoBTB2 isoforms during in vitro OL differentiation. A) The mRNA expression of the two isoforms was 
quantified by RT-qPCR.CDS (black bar), pA2, (white bar). B) The ratio of mRNAs expressions (pA2/CDS) was 
performed. Error bars show the standard deviation (SD) for at least three independent experiments. 
Using the same approach in vivo, in the ON we observed that both total mRNA and long 
RhoBTB2 isoform are distinctly expressed compared with OLs (Figure 19). The 
contribution of the pA2-derived mRNA for the total expression levels is not as 
considerable as in OLs, however its expression is very high in comparison to classical 
Rho GTPases (Figure 19A). The ratio pA2/CDS significantly increases from P2 to P14 
A B 
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(Figure 19B), but this may be due to a decrease in the total mRNA expression (Figure 
19A) rather than an increase in the levels of the longer mRNA isoform.  
 
 
Figure 19. Quantification of the relative mRNAs expression levels by RT-qPCR, of the different 
RhoBTB2 isoforms during ON development. A) The mRNA expression of the two isoforms was quantified 
by RT-qPCR.CDS (black bar), pA2, (white bar). B) The ratio of mRNAs expressions (pA2/CDS) was 
performed. Error bars show the standard deviation (SD) for at least three independent experiments. *p<0,05 
 
To measure mRNA stability we treated OPC cells with actinomycin D. The total mRNA as 
well the pA2-derived isoform was quantified by RT-qPCR (Figure 20A). Both mRNAs 
remain in the cell for more than 90 min (Figure 20B), suggesting that the longer mRNA 
produced by pA2 usage is stable and not target for degradation.  
 
 
 
Figure 20. Stability of RhoBTB2 mRNA isoforms.  A) The stability of the RhoBTB2 mRNA isoforms in OPC 
was measured by RT-qPCR after 10, 30, 60 and 90 minutes of exposure to actinomycin D. The mRNA levels 
were normalized to the untreated samples. B) The table resumes the half-life of the mRNA isoforms CDS 
(black line), pA2 (grey line); the long non coding RNA (red line) was used as control. Error bars show the 
standard deviation (SD) for at least three independent experiments. Time in minutes. 
In brief, our results demonstrate that this atypical Rho GTPase preferentially uses distal 
pAs producing longer mRNAs, in contrast to the classical Rho GTPases. However, 
RhoBTB2 mRNA t1/2(in min) 
 d0 
lncRNA 90 
CDS >90 
pA2 >90 
A 
 
A B 
B 
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similarly to classical Rho GTPases, atypical Rho GTPases do not undergo an APA switch 
during OL differentiation. Overall it is possible to infer that among Rho GTPases, APA is a 
mechanism that is gene specific. 
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1.4. In glial cells, Rho GTPases show the same pattern of APA, 
using preferentially the proximal pAs. 
APA patterns have been recently described as tissue-specific101 . Since we have observed 
a marked APA pattern for Rho GTPases in OLs, we decided to study this “cell type-
specificity effect of” in other type of glial cells. The expression of the different Rho 
GTPases mRNA isoforms was therefore tested in primary microglia and astrocytes cell 
cultures (Figure 21), which are fully differentiated cells.  
Our results show that both microglia and astrocytes appear to behave similarly to OLs, 
and present a “cell type-specific effect”. We also show that Rac1, Cdc42 Iso1 and Cdc42 
Iso2, and RhoA preferentially use the proximal pAs. For RhoBTB2 our results show that 
the longest isoform contributes for thereabout half of the total expression in microglia and 
astrocytes. In OLs, these expression levels are higher, suggesting that APA of RhoBTB2 
change in a cell-specific manner. This may explain the differences obtained between OLs 
in culture and ON (Figures 18 and 19). In glial cells the classical Rac1, both Cdc42 
isoforms and RhoA share the preferential usage of the proximal pAs forming the shortest 
mRNA isoforms whereas atypical RhoBTB2 favors the distal pAs. Thereby, it is possible 
to conclude that APA of Rho GTPases is gene- and cell-type specific.  
Recent work has shown a complete lengthening of the 3’UTRs in Drosophila CNS63 
whereas in mammalian brain this lengthening is not complete: although levels of longer 
mRNAs are higher, the shortest isoforms still continue to being expressed64. The authors 
have suggested that these differences were due to the presence of a higher percentage of 
glial cells in mammalian brain than in Drosophila CNS. Our results for the Rho GTPases 
in OLs, microglia and astrocytes support this hypothesis. 
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Figure 21. Rho GTPases mRNA isoforms quantification in different cell types. mRNA expression from 
the coding region (CDS, black bar), and the longest isoform produced (pA2, colored in white) was quantified 
by RT-qPCR. The quantification was performed either in primary A) microglia (only one experiment) and B) 
astrocytes. Error bars show the standard deviation (SD) for at least three independent experiments. 
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1.5. Rac1 mRNA undergoes 3’UTR lengthening during axonal 
growth of the cortical neurons, concomitant with an increase in 
Rac1 protein levels 
To further explore the cellular specificity of APA, and taking into account the 
differences observed between Drosophila63 and mammalian64 CNS, the pAs usage of 
Rho GTPases was accessed in rat cortical neurons. To unravel if the observed pattern 
of APA is characteristic of these genes and transversal to the cell types or if it is 
regulated in a cell-specific manner, and follow the described widespread usage of the 
distal pAs, the total mRNA and the long mRNA isoform were quantified by RT-qPCR.  
 
Strikingly, in cortical neurons, we observe an increase in the long Rac1 mRNA 
expression during axonal growth (Figure 22A and B). This finding demonstrates an 
APA switch in Rac1 mRNA in cortical neurons during axonal growth, resulting in a 
complete lengthening of the Rac1 3’UTR due to the usage of the distal pAs. This switch 
in the pAs usage provides an additional possibility of post-transcriptional regulation, 
either by miRNA/RBP-targeted degradation or by RBP-based stabilization, and 
suggests that in neurons, APA is used to control the axonal growth. In addition, this 
difference could mean that in neurons, Rac1 may have other cellular functions that not 
occur in glia. Although the described roles of Rac1 in both cell types are parallel and 
are related to the process/dendrite extension, Rac1 is also important for the axonal 
maintenance. Since the axon is a particularly long structure, Rac1 may need a 
differential regulation for the proper outgrowth and maintenance of this structure. 
Another indication that the differential expression of Rac1 isoforms could be related to 
the axonal biology is the fact that the major differences are seen in day 14 of axonal 
growth, whereas at day 0 the expression is mostly given by the usage of the proximal 
signal. Similarly to what was seen for BDNF (brain-derived neurotrophic factor) long 
mRNA isoform that localizes at the dendrites and affect it normal development and 
functions104, it is also possible that the long Rac1 mRNA isoform is involved in Rac1 
mRNA cellular localization. Supporting this hypothesis, the long 3’UTR of Rac1 contain 
several putative binding sites for RBP of the hnRNP family (Table 4), known to be 
required for mRNA export105.  
The APA pattern for Cdc42 Iso1, Cdc42 Iso2, and RhoA is similar to what was 
observed in glial cells, i.e. preferential proximal pAs selection without significant 
changes in the isoforms ratio during axonal growth (Figure 22A-B). Regarding the total 
expression of Cdc42 Iso1 and Cdc42 Iso2 mRNAs in neurons (Figure 22A) and in 
contrast to OLs (Figure 15A), we observed a drastic increase in the relative mRNA 
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expression of the Cdc42 Iso2 and a decrease in Cdc42 Iso1 mRNA expression. This 
indicates that the described brain-specific Cdc42 Iso2 31, 32  is instead neuron-specific, 
since its expression in the glia is very low. In addition this result suggests the existence 
of distinct roles for both Cdc42 protein isoforms in the CNS.  
 
Figure 22. Rho GTPases mRNA isoforms quantification during axonal growth of cortical neurons. 
A) The expression of the total (CDS, colored in black) and the longest (pA2, colored in white) mRNAs was 
quantified by RT-qPCR. B) The ratio of these mRNA expressions (pA2/CDS) is presented. Results are 
from one experiment representative of three independent experiments. 
A B 
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Next, we questioned if the different Rac1 3’UTRs would impact protein production and 
therefore is physiologically relevant. For that, we quantified total Rac1 by western blot 
at the three time points of the neuronal growth (Figure 23). 
 
Figure 23. Quantification of Rac1 protein levels during the axonal growth of cortical neurons. A) 
Total Rac1 Protein expression at day 0, 7 and 14 of axonal growth (western blot). B) Quantification of the 
protein levels. α-Tubulin was used as a control. Results are from one experiment representative of two 
independent experiments. 
Although the α-Tubulin protein was proved not to be the best control, since it varies 
from day 0 to day 7, it is possible to see a drastic increase in total Rac1 protein levels 
from day 0 to day 14. This result indicates that the longest Rac1 3’UTR leads a higher 
protein production and suggest that the longer 3’ UTR is not target for downregulation. 
This possible function for the longer 3’UTR is in accordance to previous results from 
our lab, in which the longer polo mRNA in Drosophila is required for efficient 
translation95.  
Altogether our results highlight the relevance of APA in achievement a cell-specific 
gene expression. However, the mechanisms that confer this fine-tune regulation as 
well as their functional relevance remains unknown. 
F
o
ld
 i
n
c
re
a
s
e
 o
v
e
r 
d
a
y
  
0
A B 
RESULTS & DISCUSSION 
Page 61 of 92 
1.5.1. Rac1 appears to be differentially regulated in different types of 
neurons. 
 
The neuron-specific alternative splicing mechanisms has been largely explored in the 
last few years. Recently it was demonstrated that two conserved RBPs, UNC-75/CELF 
and EXC-7/Hu/ELAV present alternative spliced isoforms according the functional type 
of the neuron where they are expressed7. The coupling between alternative splicing 
and APA has been already well described for some mammalian genes106, e.g. the Glial 
Fibrillary Acidic Protein (GFAP) in glial cells107. Although this close relationship, this has 
not been explored in different types of neurons. In order to access if the APA pattern of 
Rac1 is neuron-type-specific, we quantified the expression of the mRNA isoforms in 
hippocampal and striatal neurons (Figure 24). These two types of neurons differ in their 
morphology and functionality. Our preliminary results indicate that there are some 
differences in expression of both mRNA isoforms between the two-neuron types.  
 
Figure 24. Rac1 mRNA isoforms quantification during axonal growth of hippocampal and striatal 
neurons. The expression of the total (CDS, colored in black) and the longest (pA2, colored in white) 
mRNAs was quantified by RT-qPCR using cultured (A,B) hippocampal and (C,D) striatal neurons. B) and 
D) represent the ratio of them RNA expression (pA2/CDS) showing the variation of the pAs usage. Error 
bar represent the SD of two independent experiments. 
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Although these differences are not statistically significant and more experiments needs 
to be done, it is possible to observe that during the axonal growth in hippocampal 
neurons the total mRNA expression of Rac1 remains stable, being accompanied by a 
small decrease in the levels of the longer Rac1 mRNA isoform (Figure 24A), whereas 
in striatal neurons the total Rac1 expression decrease with no changes in the 
expression of the longest isoform (Figure 24C). In addition, we observe an opposed 
ratio of the pAs usage during the axonal growth (Figure 24B and 24D). In the 
hippocampus, neurons decrease the usage of the distal signal while in striatum this 
usage is increased. Comparing these results with those of cortical neurons it is visible 
that the pattern of the cortical neurons is more related to that presented by the striatal 
neurons (Figure 25).  
There are several different types of neurons in the brain. In the cortex there is a mixture 
of gabbaergic and glutamatergic pyramidal neurons, in the hippocampus glutamatergic 
pyramidal neurons are predominant, and striatum mostly contain gabbaergic 
interneurons. Therefore, we expected that Rac1 expression in cortical neurons would 
reflect the mixture of both types of neurons, or additionally would be similar to the 
expression observed in the hippocampus, given the morphological similarities and the 
importance of Rac1 for that morphology 23, 36, what it has not observed. 
 
Figure 25. Comparison of the Rac1 mRNA isoform expression ratio (pA2/CDS) in different types of 
neurons during axonal growth. Error bars represent the SEM of the three (for cortex) or two (for 
hippocampus and striatum) independent experiments. 
The activity of Rho GTPases, in particular Rac1, is regulated by the neuronal activity 
through the activation of glutamate receptors 108, 109, thus we hypothesise that APA is 
regulated by the same signal.  
 
 
RESULTS & DISCUSSION 
Page 63 of 92 
Although preliminary these results indicate that APA plays a role in fine-tuning gene 
expression, which is specific of the cell type. Furthermore, this data suggests a 
connection between the usage of alternative 3’UTRs and the function of the gene in 
each cell. 
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1.6. Candidate RBPs to regulate Rac1 3’UTR. 
In the brain, there are two key players in the regulation of the gene expression: the 
longest 3’UTRs of the mRNAs and the expression of neuron-specific RBPs110. RBPs 
may regulate APA co-transcriptionally, and/or may bind to the 3’UTR of a particular 
mRNA regulating its fate. Since our results demonstrated a distinct Rac1 APA pattern 
among the different brain cells, we hypothesized the existence of a coupling between 
different expressed 3’UTRs, and a differential expression of specific RBPs, implying 
possible role in regulating Rac1 expression. Therefore, we performed an in silico 
analysis to identify the RBPs that potentially bind Rac1 3’UTR. Table 4 depicts RBPs 
(with a score over 70%) that have putative binding sites in both Rac1 3’UTRs (light 
green), only in the shortest (mild green) or in the longest (dark green) isoforms. 
 
 
Figure 26. mRNA sequence of the Rac1 3´UTR. The putative binding sites for several RBPs are 
highlighted. 
We next quantify the expression of RBPs that have putative binding sites in both 
mRNA isoforms, and also, specific RBPs that bind only to one isoform. We quantified 
the expression of Nova1 (Neuro-oncological ventral antigen 1), Ptbp1 (polypyrimidine 
tract binding protein 1) and Ptbp2 (polypyrimidine tract binding protein 2), all with 
TAAATGTCTGAGCCCCTCCCTCGGTCTTGGTCCCTGGAGCCTTTGTACGCTTTGCTCAGAAAATGGCGGAGTC
TTCGCGTCTGATGCCAAGTTTTTGTTACAGATTAATTTTTCCATAAAACCATTTTGAACCAATGAACCAGTCAGTA
ATTTTAAGGTTCTGTTTTAAATGTAAGAATTCCAACTTACAGTCTATTAAAATTCAGCCCTAAAATGAC|AAAGCC
TTCTTAAAGCCTTATTTTTCAAAATCCCCTATTCTTGCTCAGATTAAGAATTGCCAAAATACCTTGTGAACTAAGT
TGCGTTGTGCTGAGAACATGTAAGCACTAAGCTGTTGAGAGACTTTGTCCTTAAGAAGACTGCAGCTTCTGGGC
TCAGGGGTGCAGACCCTCCCGTAGCTCCCAGACCGTGTGACACAGCACAGCCTCCTTAATGACACGCTGCCA
TGTAACGCACCTGTAACTTATCAGCCCATGCTCATTACGTAACTTTGTACTGTACGTCACGATGGGTGTAACAG
CTCTGCTCTTTGATTTCATAGTGAGTTCTCTAAAATACCAGCTGACCGGCTTCTGCAGGCTTTGAACAGAACTCT
GGCTCCTGTGTTGCCTCTAACGAAGTATTCTGTTCCTAGTCGTGGGTGTGCTGGGTGGAGTGTGTGAAACACG
ACGTCATCAAAGGAGACAGACAGTATTTTGACTAATATGAAGTAGAGATTAATTTACACTACATTGTACATGGAG
TAATTCAACTGAATAAAAGTGTCACGGGTAAAGCTTTTTAACGGTTAATTTCTGTCAAACAGTAGATGACAAATG
GCCGATCTTATCAGTGTCTCTCTTGAGCCCCCCTTCCCCCTGCTGTCCCTCCCCAGATGGGGCGTTGAGTCCA
TATTTAAACTGGCCATCCTCACAGTTGCTAACTTAGCAAGTGCTTTTCTTTAGGACCCCCTTCTTAACGAGCAAT
ATGTCTGACCTGTACTATAAGATCTTTCTGATAATGCATTCGGAGATTTTTTTGGTAGATAGTAGAAGTGCGTTC
CTGTTTTCACCTTCCTTTACTCAGCTGACTAGTGCTTCCCTTCGTTTTCTAGTAACTGGGTGTAGAAATCACGTG
CTGCGGCTTTACAGTTTTTAAACTATTTTAGATATTCTGAAACATCACTGTCTTGCCAGAGTACCAACACTGTCA
TGTGATTGATGCCGCCCCCTCTAGACCTCACCCACGCGGACACATGCTTCCCGTACCTTTGGGTCTGTGAGGT
TCTGTCAAGCGCTAGTGCTAACGCCGTTCTGTACAACCTAACTCACTGGCAAGAACACAGTGTTGGGCCTTTC
GACCACTAGAACAAACTTTTTTCAATTGACAGTTACAGAATTGTGGAGTGTTTTTACATTGATCTTTTGCTAATGC
AGTTAGCAGTATGTTTTGCATGTATGACTTAATAAATCCTTGAATC| 
 
Pum2Nova1PtbpElavlYbx1 
Rac1 pAs KHSRP YTHDC1 RBMX KHDRBS3 PUM2 SFRS1 MBNL1 ELAVL1 QKI ACO1
pA1
pA2
PTB Nova1 hnRNPF ELAVL2 SFRS2 SNRPA PABPC1 FUS SFRS9 EIF4B
pA1
pA2
VTS1 SFRS13A YBX2-A SAP-49 YBX1 RBM4 hnRNPU hnRNPH1 hnRNPA2B1 hnRNPA1
pA1
pA2
Table 4. RBPs with putative binding sites in Rac1 3’UTR. 
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putative binding sites for both Rac1 mRNA isoforms (Figure 26), in OLs during 
differentiation and in neurons during axonal growth (Figure 27). Although these RBPs 
are mostly known for their role in alternative splicing, their important functions in mRNA 
3’ end processing have already been well established98, 111, 112. In OLs, Nova1 mRNA 
expression levels showed a 2-fold increase at day 3 and a gradual decrease up to day 
7 (Figure 27A). In contrast, neurons present nearly a 2-fold increase at day 14, without 
any changes in the two first time points (Figure 27B). The increase in Nova1 mRNA 
expression corresponds to the time point, which in OLs Rac1 mRNA reaches its total 
and pA2-derived expression levels (Figure 15A), and in cortical neurons where there is 
a peak in the expression of the longer isoform (Figure 22A). These results suggest that 
Nova1 could act as a Rac1 APA regulator, by activating the distal PAS selection. 
Nova1 has been shown to regulate APA by binding to the flanking regions of proximal 
pAs, blocking the binding of the core cleavage/polyadenylation factors, thereby 
promoting the usage of the distal pAs that are available for the cleavage machinery 
assemblage111. Thus, it is likely that, at least in neurons, Nova1 is regulating Rac1 
APA, promoting the usage of the longer mRNA isoform at day 14 of axonal growth. 
 
Regarding Ptbp, we observe a switch from Ptbp1 to Ptbp2 (also known as neuronal 
Ptb) expression during neuronal differentiation (Figure 27D and 27F), as previous 
described5. Interestingly, we also observe the same Ptbp1/Ptbp2 switch during OL 
differentiation (Figure 27C and 27E). Ptbp1 mRNA levels decrease gradually during the 
OLs differentiation, while Ptbp2 levels increase up to day 5, although these changes 
are not statistically significant (Figure 27C and 27E). The same tendency occurs in 
cortical neurons during axonal growth: expression of Ptbp1 undergoes a drastic 
decrease from day 0 to day 7 (Figure 27D) whilst the increase in Ptbp2 expression is 
very slight (Figure 27F). The function of this switch is well established in alternative 
splicing where Ptbp1 downregulates Ptbp2 co- and post-transcriptionally5, 113. 
 
Individually, Ptb proteins can affect the mRNA stability through the 3’UTRs114, 115, and 
also polyadenylation98, 112. In the C2 complement gene, Ptbp1 can activate the 
polyadenylation through bind to it pAs USE98, however this effect seems to be in a 
dose-dependent manner whereas either Ptbp1 knockdown or overexpression results in 
a decrease of C2 complement expression112. Our data indicates that, Ptbp1 expression 
levels in OLs remains approximately stable during differentiation, whereas in neurons 
there is a drastic decrease of its expression.  
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Figure27. Quantification of mRNA expression levels of RBPs during OLs differentiation and axonal 
growth of neurons. The mRNA expression of Nova1 (A,B), Ptbp1 (C,D) and Ptbp2 (E,F) was quantified 
by RT-qPCR using in vitro differentiated OLs (A,C,E) or neurons (B,D,F). Error bars represent the SD of 
three independent experiments.*p<0,05, **p<0,01. 
 
If Ptbp1 has the same role in regulation of PA in Rac1 as in C2 complement, the 
differences in its expression could explain the differences in pAs selection between 
OLs and cortical neurons. Since the binding site for Ptbp1 is upstream of the proximal 
Rac1 pAs, it can be activating during OL differentiation and in the early stages of 
neuronal axon growth. However the function of Ptbp1/Ptbp2 switch in 3’end processing 
are not known, is possible to hypothesize that the decrease in Ptbp1 expression may 
be leading to the usage of the distal Rac1 pAs accompanied by the stabilization of the 
longest mRNA isoform through the increase of Ptbp2 expression in cortical neurons.   
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Another potential effect of the Ptbp proteins in Rac1 regulation is at cytoplasm level. 
Recent studies found that Ptbp1 regulates Rac1 by promoting miRNA targeting, 
through the formation of a secondary mRNA structure (when Ptbp1 is bound), which 
makes the target site available to the miRNA 124 (miR-124)116. We observed that the 
Ptbp binding site is close to the miR-124 target site in the long Rac1 3’UTR. Therefore, 
the Rac1 regulation in neurons could be done by this mechanism, since the increase in 
long Rac1 mRNA corresponds to the time point where Ptbp1 expression decreases. 
Thus, is no longer available for promoting the miRNA targeting of Rac1 3’UTR. 
In addition, the switch from Ptbp1 to Ptbp2 in neuronal differentiation was also 
described as being mediated by miR-124, since it can suppress Ptbp1 expression.117 
This down regulation of Ptbp1 allows the increase of Ptbp2 expression, as Ptbp2 is 
sufficient to induce the neuronal phenotype in fibroblasts116, it is likely that the switch 
Ptbp1/Ptbp2 have a role in the neuronal axon growth. In addition, in OLs the basal level 
of Ptbp1 that is maintained throughout differentiation could modulate the degradation of 
the longest 3’UTR by miRNAs. Thus the switch of Ptbp proteins may be leading to the 
differences between OLs and neurons in Rac1 isoforms expression.  
Further studies are required to confirm this hypothesis, however this cross regulation 
through Ptbp1/Ptbp2 and miRNAs can be fundamental players in the regulation of the 
Rac1 expression. 
 
Only two RBPs were predicted to bind to the shortest Rac1 3’UTR, one of which is 
Elavl2 (ELAV like neuron-specific RNA binding protein 2) (Table 4). There is a high 
conservation of the consensus binding sites among Elavl (also known as Hu) proteins, 
which are the AU-rich elements (AREs)69, 118. Elavl1 was recently described as a 
mediator of neuronal 3’UTRs extension in Drosophila119. Interestingly, in one genome-
wide study, using brain tissue and searching for Elav4 targets, one binding site in Rac1 
3’UTR was found (Toma Tebaldi, personal communication). We therefore quantified 
the expressions of Elavl1 and Elavl4 in cortical neurons (Figure 28). However, our 
results have shown that Elavl1 and Elavl4 expression levels do not change during 
axonal growth. 
Elavl proteins are known for their multiple functions on mRNA: local transcription rate 
enhancement, translation repression or enhancement, alternative splicing, nuclear 
export of mRNA, mRNA stabilization (Elavl1 also affect mRNA destabilization) and 
APA. While Elavl1 is ubiquitously expressed, Elavl4 is neuron-specific and have critical 
roles in neuronal development and function. Elavl4 have indeed an essential role in the 
terminal differentiation of the neurons, specifically in dendritic and axonal outgrowth.120, 
121
 Thus, the absence of variation in Elavl1 and Elavl4 mRNA levels does not imply a 
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lack of function in the Rac1 3’UTR regulation. They may affect Rac1 mRNA by 
modulating their cellular localization, for example. Further studies are required to 
address this issue. 
 
Figure 28. Quantification of mRNA expression levels of RBPs during OLs axonal growth of cortical 
neurons. The mRNA expression of A) Elavl1, B) Elavl4 was quantified by RT-qPCR using cultured cortical 
neurons. Error bars represent the SD of three independent experiments. 
Concerning the putative RBPs present only in the longest Rac1 3’UTR, we decided to 
further study Ybx1 (Y box binding protein1). Ybx1 binds to the mRNA and participate in 
pre-mRNA transcription and splicing, mRNA packaging and regulation of its stability 
and translation122. Our results have revealed an interesting pattern in OLs 
differentiation. Ybx1 mRNA present a peak of expression at day 3 of differentiation, 
followed by a drastic decrease at day 5 (Figure 29A). This mRNA expression pattern is 
accompanied by the protein levels (Figure 29B). To confirm that Ybx1 is able to bind to 
Rac1 mRNA, we performed a RNA-immunoprecipitation (RIP) assay. Our results have 
shown that Ybx1 clearly binds to Rac1 mRNA (Figure 29C). Although this technique 
does not allow us to map the binding site of Ybx1 to Rac1 mRNA, it is very likely 
through 3’UTR, as our in silico data indicates. 
The involvement of Ybx1 in mRNA translation regulation has been described as result 
of variations in Ybx1/mRNA ratio: low ratios promote mRNA translation whereas high 
ratios make the mRNA inaccessible to translation and also to degradation122. Thus, the 
Rac1 could be regulated in a similar manner, i.e. the increase at day 3 of Ybx1 
corresponds to an increase in Rac1 expression (increasing the ratio), which could 
indicate that part of the Rac1 mRNA at this stage is inaccessible to translation, and we 
can hypothesized that is being transported into the processes, since Ybx1 is a major 
component of the mRNPs, the structures that transport the mRNAs in the cell122. At day 
5 the Ybx1 protein levels decrease and Rac1 mRNA expression continue to increase 
(decreasing the ratio). It is possible that at this stage the mRNA is being locally 
translated.  
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Figure 29. YBX1 expression and Rac1 mRNA binding during OL differentiation. A) The YBX1 mRNA 
expression was quantified by RT-qPCR in OPC/OL at day 0, day3 and day 5of differentiation. B) The 
proteins levels were measured by Western blot and the respective bands quantification. C) YBX1-Rac1 
mRNA interaction was assessed by RIP assays. *p<0.05; **p<0.01; ****p<0.0001. 
 
Altogether, our results indicate that the expression of the RBPs studied is cell type 
dependent. As we found that these proteins putatively bind to Rac1 3’UTR and 
confirmed experimentally this binding for Ybx1, it is plausible that their expression 
variations observed may impact on the regulation of Rac1 mRNA isoforms. 
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2. Cdc42 isoforms functions in CNS and PNS myelination 
 
2.1. Potential different roles of Cdc42 isoforms in OL and SC 
differentiation. 
The myelination is a common process of both CNS and PNS, which requires the full 
differentiation and maturation of the OLs or SC respectively. This process is Cdc42-
dependent in both cell types38, 40, however Cdc42 present two alternative spliced 
isoforms (Figure 30) with different features31, 32, 123, whose role in myelination remains 
unrevealed.   
 
These two Cdc42 mRNA isoforms are translated in two different proteins with the same 
size (191 aa.), which only vary in the a.a. sequence from position 182 to 191, the 
region that corresponds to the membrane localization domain29. To start to investigate 
the biological relevance of these two Cdc42 Isoforms in differentiation and myelination, 
we quantified their mRNA levels in OLs, in ON and in SN. Since Cdc42 Iso2 mRNA 
expression levels in non-neuronal cells is lower than those of Cdc42 Iso1, and to 
highlight the variation in the relative expression of the two isoforms during the cell 
differentiation, the ratio between the mRNA expression of the 2 isoforms was 
determined (Figure 31). In OLs we observed that during differentiation Cdc42 Iso1 
expression increases relatively to Cdc42 Iso2 (Figure 31A). However, in the in vivo 
system (ON) this difference is not observed (Figure 31B), probably due to the influence 
of the axonal portion present in ON, since Cdc42 Iso2 is highly expressed in neurons 
and its expression increases with axonal growth (Figure 22A). Surprisingly, the result 
from SN shows a significant increase in the relative expression of the Cdc42 Iso1 
(Figure 31C) during myelination (from P2 to P30).     
Figure 30. Schematic representation of the Cdc42 gene splicing variants. Cdc42 gene has 7 exons, 
and exons 6 and 7 undergo exon skipping to generate Cdc42 Iso1 or Iso2, respectively, containing different 
3’UTRs. 
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Figure 31. mRNA expression ratios of the Cdc42 isoforms during OL, ON and SC differentiation. 
The ratio Cdc42 Iso1/Cdc42 Iso2 expression was determined in A) OLs, B) ON and C) SN at different time 
points of differentiation. Error bars represent the SD of at least three independent experiments. *p<0.05; 
***p<0.001 
 
These observations strongly support the hypothesis that the two spliced isoforms of 
Cdc42 have different roles in differentiation and myelination of both OLs and SN, with a 
more pronounced role in the last one. From these results we hypothesize that Cdc42 
Iso2 is more required in the early stages, while the Cdc42 Iso1 is more preponderant in 
the later stages of differentiation. It was recently demonstrated that in SC, Cdc42 is 
recruited and activated at the plasma membrane by Frabin/Fgd4 (a Cdc42 GEF) and, 
this function is critical to proper myelin maintenance in the adulthood124, however in the 
pup stage Frabin/Fgd4 is not able to activate Cdc42. On the other hand, Cdc42 
knockout mice show a decrease in SC proliferation (unpublished data from João B. 
Relva’s Lab). However, in both situations was considered the total Cdc42. Altogether, 
these results are in accordance with the suggestion that Cdc42 Isoforms have different 
roles, at least in SC. Thus Cdc42 Iso1 could be affecting differentiation and 
myelination, and Cdc42 Iso2 might be involved in the proliferation of myelinating cells. 
To unravel the potential function of the two Cdc42 proteins, the CG4 cell line (a cell line 
of OLs) was transfected with constitutively active Cdc42 Iso1 and Cdc42 Iso2 plasmids 
with a GFP tag (Figure 33). CG4 cells were used in order to obtain more transfection 
efficiency, since the primary OLs are difficult to transfect. Of note, the levels of Cdc42 
mRNAs expression was also measured in this cell line to confirm that they express 
similar levels as primary OLs (data not shown). Albeit the lower percentage of the 
transfected cells, it is possible to analyse the results due to the selection of the positive 
cells that express GFP. The preliminary immunofluorescence images show that the 
Cdc42 Iso2 seems to cause an arrest in the cell differentiation with a simultaneous 
decrease in process complexity (Figure 32C-E). This phenotype is very clear when 
A C B 
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comparing GFP-positive cells with non-transfected cells at day 3 and 5. At day 3, non-
transfected cells already present numerous processes while GFP-positive are still 
bipolar (Figure 32D). Also, at day 5, the delay in differentiation is visible, with the 
transfected cell having some processes extensions. However, these processes seem 
to be shortest and have less branching complexity than the non-transfected cells 
(Figure 32E). The results from Cdc42 Iso1 transfection have shown that at day 0 the 
cells remain phenotypically normal (Figure 32A), whereas at day 5 GFP-positive cells 
appear to present longest processes when compared with negative cells (Figure 32B). 
Regarding the localization, the results have suggested that the exogenous proteins 
localize differentially, at least at day 5. Thus, at the later stages of the differentiation, 
the GFP signal of Cdc42 Iso1 transfected cells is localized in the soma (Figure 32B), 
whereas in the Cdc42 Iso2 transfection the signal is present in the soma and 
processes, and the protein seem to be in the cytoplasmatic membrane (Figure 32E).   
 
These results fit with our previous hypothesis of the different functions for the Cdc42 
protein isoforms. Moreover, they advance a role for Cdc42 Iso1 in differentiation, since 
transfected cells present longer processes, and a role for Cdc42 Iso2 in proliferation, 
since the positive cells retain for a longer time the proliferative phenotype, even in the 
presence of differentiation factors. The results from the membrane localization of the 
Cdc42 Iso2 are also in concordance with previous studies. This demonstrates in one 
hand, that the specific dual lipidification of this protein increases its affinity for the 
membranes31 and, in the other hand that the a.a. changes (relative to the Cdc42 Iso1) 
in the membrane localization domain prevents the interaction with the Rho GDIα, that is 
an inhibitor of the Rho GTPases activation 33. Although these are preliminary results, 
they highlight the relevance of both protein isoforms during OLs differentiation, and the 
existence of different roles in this process. Further studies need to be done to confirm 
and dissect the role of the Cdc42 isoforms in CNS and PNS during differentiation and 
myelination.    
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Figure 32. Constitutive expression of Cdc42 Isoforms in CG4 cells. (A, B) Cdc42 Iso1 and (C, D, E) 
Cdc42 iso2 plasmids with GFP tag were constitutively expressed in CG4 cells. CG4 cells were collected at 
(A, C) day 0, (D) day 3 and (B, E) day 5. The green staining marks the Cdc42 proteins, the red tubulin and 
in blue the DAPI. Amplification 40x. 
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2.2. Role of miRNAs in regulation of the Cdc42 isoforms 
expression. 
The Cdc42 mRNAs not only have differences in the alternative exons that are included 
(by alternative splicing), but also contain different 3’UTRs (Figure 30). Consequently, 
Cdc42 Iso1 and Cdc42 Iso2 could be differential regulated through its 3’UTRs, by RBP 
and miRNAs targeting. Since the shortest 3’UTRs of the two Cdc42 mRNA isoforms 
are the most expressed, we used this 3’UTRs to perform an in silico analysis to search 
for putative miRNAs target sites.  
 
Figure 33. Representation of the Cdc42 Iso1 and Cdc42 Iso2 shortest 3’UTR highlighting the 
putative target sites for miRNAs. The target sites are colored in the same color of the respective miRNA, 
in red are represented the pAs. 
Three miRNAs databases were assessed and only those miRNAs that were present in 
all of them were considered and represented in Figure 33. Curiously the two Cdc42 
isoforms have completely different putative binding site for miRNAs. Furthermore, to 
restrict the number of miRNAs, we selected those that have some described relation 
with Cdc42 or OLs. The miR-137 and miR-195-5p were demonstrated as regulators of 
Cdc42 in some carcinoma models81, 125, 126, and the cluster miR-17-92 was involved in 
the control of cell number of OLs81. In order to understand if Cdc42 Iso1 and Cdc42 
Iso2 expression could be modulated by these miRNAs during the OL differentiation, 
their expression was quantified by RT-qPCR using specific probes. Our results have 
shown that the expression of miR-195 increases at 3 days post differentiation (Figure 
34), the time point from each the expression of Cdc42 Iso2 starts to decrease (Figure 
15). Interestingly, the expression of this miRNA decreases from day 3 to day 7, 
accompanying the decrease in Cdc42 Iso2 expression. These results may indicate that 
the increase in miR-195 expression in the first 3 days of differentiation downregulates 
Cdc42 Iso2 expression. 
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Regarding the expression of the miR-137 and miR-92a, the results show a similar 
expression pattern, with an increase at day 3 followed by a decrease up to day 7 
(Figure 34). Analysing the expression pattern of Cdc42 Iso1 (Figure 15), we observed 
that until day 3 the relative expression is not altered, and from day 3 onwards there is 
an increase in Cdc42 Iso1 expression. This suggests that miR-92a and miR-137 may 
regulate Cdc42 Iso1 basal levels in the first days of differentiation, and only upon a 
decrease in the expression levels of these miRNA, the expression of Cdc42 Iso1 starts 
to increase. However, further studies are needed to dissect the potential role of these 
miRNAs in the regulation of Cdc42 isoforms. 
 
 
Figure 34. miRNAs expression during OLs differentiation. The mRNA expression of miR-92a, miR-
137, and miR-195 was quantified by RT-qPCR using OLs. Error bars represent the SD of two independent 
experiments for miR-137 and miR-195. The expression of miR-92a was analyzed once. 
The Cdc42 isoforms can also being regulated either by other miRNAs or competition 
between miRNAs and RBPs or, by differential expression of RBPs.  
Thus, an important issue to be addressed in the future is the existence of different 
RBPs binding sites in one or another Cdc42 isoforms. Potential candidates are the 
PTBP proteins, since they control Cdc42 splicing events117. Ptbp1 is responsible for the 
inclusion of the exon 7 in Cdc42 Iso1, and Ptbp2 for the inclusion of the exon 6 in the 
Cdc42 Iso2117. Given this, it is likely that Cdc42 isoforms are being regulated by the 
interaction of various mechanisms in a time-dependent manner. Thereby, the Cdc42 
isoforms appears to have a critical function in OL differentiation. However, the role of 
each isoform and the molecular mechanisms behind its differential expression during 
differentiation still remains elusive. 
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APA is a co-transcriptional mechanism that allows gene regulation through the differential 
expression of different 3’UTRs in a very specific manner. Therefore, APA is used to 
regulate diverse cellular processes and conditions.   
 
From the results of this work it is possible to conclude that the ‘classically activated’ Rac1, 
Cdc42 and RhoA have different mRNA isoforms produced by APA in the 3’UTR, which 
can be subject of regulation by RBPs and miRNAs. We found that the relative expression 
of the different mRNA isoforms during OL differentiation do not change, and the proximal 
signal is always the most used signal, in contrast with the data obtained from genome-
wide studies64. Therefore, it is tempting to speculate that this pattern of APA is due to the 
specificity of the classical Rho GTPAses, since their function is fine-tune regulated at the 
protein level through activation/inactivation by GEFs, GAPs and GDIs. Consequently they 
choose preferentially the proximal site to produce enough amounts of protein that can be 
regulated itself. This hypothesis was further supported by the results from the atypical 
RhoBTB2, which have showed a total usage of the distal pA throughout OL differentiation. 
Since RhoBTB2 proteins are constitutively active, they may require an upstream 
regulatory mechanism at the mRNA level, and for that reason the distal pAs is selected for 
production of the longest 3’UTRs, more prone to regulation. Remarkably, the APA pattern 
of the Rho GTPases studied in this thesis seems to be transversal to all glia cells, 
revealing a cell specific behavior of this process, a mechanism not yet described. 
Interestingly, when APA of Rac1 Rho GTPase was analyzed in cortical neurons, we 
observed that Rac1 3’UTR undergoes a complete lengthening through the usage of the 
distal pAs during axonal growth. This is in contrast to other previously described genes in 
other cell types and conditions that express the shortest mRNAs to produce higher 
amounts of protein. In neurons, lengthening of the Rac1 mRNA leads to higher protein 
levels, according to what is described in high throughput studies for APA in the brain. This 
thesis also provides indications for the mechanism of regulation of the 3’UTRs extension 
in neurons by the differential expression of RBPs, namely the brain specific Nova1. Albeit 
the APA process was characterized, the biological function of the expression of long Rac1 
3’UTR stills requires a deep investigation. This work demonstrated for the first time, that 
APA is a gene specific process that allows the achievement of a cell specific regulation of 
genes that are ubiquitously expressed. 
Altogether, we provide for the first time evidences that APA is a gene and cell specific 
mechanism, and that we need to have caution in the extrapolation of the genome wide 
studies when we are dealing with a mixture of cells.  
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Additionally, this work provides for the first time evidences for distinct functions of Cdc42 
alternative isoforms in OL differentiation and myelination. Although the molecular 
mechanism underlying the differential expression of Cdc42 isoforms and their functional 
relevance remains unknown, these findings open the door towards a more complete 
understanding of the myelination and remyelination process in CNS and PNS. 
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Alternative Polyadenylation in Rho GTPases 
In contrast with the genome-wide data about APA63, 64, this work puts forward a 
mechanism that is more gene and cell specific. Nevertheless, several issues need to be 
address in the future: 
• What is the biological importance of the longest Rac1 mRNA in cortical neurons? 
• Is Rac1 3’UTR affecting its cellular localization? 
• What are the molecular regulators of the Rac1 3’ end extension? 
 
 
Cdc42 isoforms functions in CNS and PNS myelination    
Cdc42 plays an important role in CNS and PNS myelination38, 40. We have found that the 
two isoform are expressed in both CNS and PNS glial cells, still the relevance of this 
findings remains elusive. Therefore, several important questions keep unanswered: 
• What is the function of both Cdc42 Isoforms in the CNS and PNS?  
• How are the Cdc42 isoforms gene regulated in the CNS and PNS? 
• Different Cdc42 isoforms play different roles in the remyelination process of the PNS? 
 
 
To unravel these points will open new avenues for the development of new strategies for 
the treatment of neurological diseases. 
  
  
  
  
  
 
BIBLIOGRAPHY 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
BIBLIOGRAPHY 
Page 87 of 92 
 
1. PURVES D. Neuroscience. In: PURVES D, AUGUSTINE GJ, FITZPATRICK D, HALL WC, LAMANTIA A-
S, MCNAMARA JO, et al., eds. Neuroscience: Sinauer Associates, Inc., 2004:1-26. 
2. Dotti CG, Sullivan CA, Banker GA. THE ESTABLISHMENT OF POLARITY BY HIPPOCAMPAL-
NEURONS IN CULTURE. Journal of Neuroscience 1988; 8:1454-68. 
3. Polleux F, Snider W. Initiating and Growing an Axon. Cold Spring Harbor Perspectives in Biology 
2010; 2. 
4. Meza-Sosa KF, Pedraza-Alva G, Perez-Martinez L. microRNAs: key triggers of neuronal cell fate. 
Frontiers in Cellular Neuroscience 2014; 8. 
5. Coutinho-Mansfield GC, Xue Y, Zhang Y, Fu X-D. PTB/nPTB switch: a post-transcriptional 
mechanism for programming neuronal differentiation. Genes & Development 2007; 21:1573-7. 
6. Hobert O, Carrera I, Stefanakis N. The molecular and gene regulatory signature of a neuron. 
Trends in Neurosciences 2010; 33:435-45. 
7. Norris AD, Gao S, Norris ML, Ray D, Ramani AK, Fraser AG, et al. A Pair of RNA-Binding Proteins 
Controls Networks of Splicing Events Contributing to Specialization of Neural Cell Types. Molecular Cell 
2014; 54:946-59. 
8. Nave K-A, Werner HB. Myelination of the nervous system: mechanisms and functions. Annual 
review of cell and developmental biology 2014; 30:503-33. 
9. Pfeiffer SE, Warrington AE, Bansal R. The oligodendrocyte and its many cellular processes. 
Trends in cell biology 1993; 3:191-7. 
10. Jackman N, Ishii A, Bansal R. Oligodendrocyte Development and Myelin Biogenesis: Parsing Out 
the Roles of Glycosphingolipids. Physiology 2009; 24:290-7. 
11. Liu J, Casaccia P. Epigenetic regulation of oligodendrocyte identity. Trends in Neurosciences 
2010; 33:193-201. 
12. Jacob C, Lebrun-Julien F, Suter U. How Histone Deacetylases Control Myelination. Molecular 
Neurobiology 2011; 44:303-12. 
13. Swiss VA, Nguyen T, Dugas J, Ibrahim A, Barres B, Androulakis IP, et al. Identification of a Gene 
Regulatory Network Necessary for the Initiation of Oligodendrocyte Differentiation. Plos One 2011; 6. 
14. Emery B. Transcriptional and post-transcriptional control of CNS myelination. Current Opinion 
in Neurobiology 2010; 20:601-7. 
15. Simons M, Trajkovic K. Neuron-glia communication in the control of oligodendrocyte function 
and myelin biogenesis. Journal of Cell Science 2006; 119:4381-9. 
16. Madaule P, Axel R. A NOVEL RAS-RELATED GENE FAMILY. Cell 1985; 41:31-40. 
17. Bar-Sagi D, Hall A. Ras and Rho GTPases: A family reunion. Cell 2000; 103:227-38. 
18. Jaffe AB, Hall A. Rho GTPases: Biochemistry and biology. Annual Review of Cell and 
Developmental Biology 2005; 21:247-69. 
19. Boureux A, Vignal E, Faure S, Fort P. Evolution of the Rho family of Ras-like GTPases in 
eukaryotes. Molecular Biology and Evolution 2007; 24:203-16. 
20. Bustelo XR, Sauzeau V, Berenjeno IM. GTP-binding proteins of the Rho/Rac family: regulation, 
effectors and functions in vivo. Bioessays 2007; 29:356-70. 
21. Aspenstrom P, Ruusala A, Pacholsky D. Taking Rho GTPases to the next level: The cellular 
functions of atypical Rho GTPases. Experimental Cell Research 2007; 313:3673-9. 
22. Cherfils J, Zeghouf M. REGULATION OF SMALL GTPases BY GEFs, GAPs, AND GDIs. Physiological 
Reviews 2013; 93:269-309. 
23. Govek EE, Newey SE, Van Aelst L. The role of the Rho GTPases in neuronal development. Genes 
& Development 2005; 19:1-49. 
24. Feltri ML, Suter U, Relvas JB. The Function of RhoGTPases in Axon Ensheathment and 
Myelination. Glia 2008; 56:1508-17. 
25. Ng JL, Luo LQ. Rho GTPases regulate axon growth through convergent and divergent signaling 
pathways. Neuron 2004; 44:779-93. 
BIBLIOGRAPHY 
Page 88 of 92 
 
26. Auer M, Hausott B, Klimaschewski L. Rho GTPases as regulators of morphological 
neuroplasticity. Annals of Anatomy-Anatomischer Anzeiger 2011; 193:259-66. 
27. Bosco EE, Mulloy JC, Zheng Y. Rac1 GTPase: A "Rac" of All Trades. Cellular and Molecular Life 
Sciences 2009; 66:370-4. 
28. Heasman SJ, Ridley AJ. Mammalian Rho GTPases: new insights into their functions from in vivo 
studies. Nature Reviews Molecular Cell Biology 2008; 9:690-701. 
29. Johnson DI. Cdc42: An essential Rho-type GTPase controlling eukaryotic cell polarity. 
Microbiology and Molecular Biology Reviews 1999; 63:54-+. 
30. Chen F, Ma L, Parrini MC, Mao X, Lopez M, Wu C, et al. Cdc42 is required for PIP2-induced actin 
polymerization and early development but not for cell viability. Current Biology 2000; 10:758-65. 
31. Kang R, Wan J, Arstikaitis P, Takahashi H, Huang K, Bailey AO, et al. Neural palmitoyl-proteomics 
reveals dynamic synaptic palmitoylation. Nature 2008; 456:904-9. 
32. Wirth A, Chen-Wacker C, Wu Y-W, Gorinski N, Filippov MA, Pandey G, et al. Dual lipidation of 
the brain-specific Cdc42 isoform regulates its functional properties. Biochemical Journal 2013; 456:311-
22. 
33. Nishimura A, Linder ME. Identification of a Novel Prenyl and Palmitoyl Modification at the CaaX 
Motif of Cdc42 That Regulates RhoGDI Binding. Molecular and Cellular Biology 2013; 33:1417-29. 
34. Zhou X, Zheng Y. Cell Type-specific Signaling Function of RhoA GTPase: Lessons from Mouse 
Gene Targeting. Journal of Biological Chemistry 2013; 288:36179-88. 
35. Gualdoni S, Albertinazzi C, Corbetta S, Valtorta F, de Curtis I. Normal levels of Rac1 are 
important for dendritic but not axonal development in hippocampal neurons. Biology of the Cell 2007; 
99:455-64. 
36. Hall A, Lalli G. Rho and Ras GTPases in Axon Growth, Guidance, and Branching. Cold Spring 
Harbor Perspectives in Biology 2010; 2. 
37. Luo LQ, Hensch TK, Ackerman L, Barbel S, Jan LY, Jan YN. Differential effects of the Rac GTPase 
on Purkinje cell axons and dendritic trunks and spines. Nature 1996; 379:837-40. 
38. Benninger Y, Thurnherr T, Pereira JA, Krause S, Wu X, Chrostek-Grashoff A, et al. Essential and 
distinct roles for cdc42 and rac1 in the regulation of Schwann cell biology during peripheral nervous 
system development. Journal of Cell Biology 2007; 177:1051-61. 
39. Guo L, Moon C, Niehaus K, Zheng Y, Ratner N. Rac1 Controls Schwann Cell Myelination through 
cAMP and NF2/merlin. Journal of Neuroscience 2012; 32:17251-61. 
40. Thurnherr T, Benninger Y, Wu X, Chrostek A, Krause SM, Nave K-A, et al. Cdc42 and Rac1 
signaling are both required for and act synergistically in the correct formation of myelin sheaths in the 
CNS. Journal of Neuroscience 2006; 26:10110-9. 
41. Liang XQ, Draghi NA, Resh MD. Signaling from integrins to Fyn to Rho family GTPases regulates 
morphologic differentiation of oligodendrocytes. Journal of Neuroscience 2004; 24:7140-9. 
42. Kim Y, Sung JY, Ceglia I, Lee K-W, Ahn J-H, Halford JM, et al. Phosphorylation of WAVE1 
regulates actin polymerization and dendritic spine morphology. Nature 2006; 442:814-7. 
43. Ramos S, Khademi F, Somesh BP, Rivero F. Genomic organization and expression profile of the 
small GTPases of the RhoBTB family in human and mouse. Gene 2002; 298:147-57. 
44. Lutz CS, Moreira A. Alternative mRNA polyadenylation in eukaryotes: an effective regulator of 
gene expression. Wiley Interdisciplinary Reviews-Rna 2011; 2:22-31. 
45. Di Giammartino DC, Nishida K, Manley JL. Mechanisms and Consequences of Alternative 
Polyadenylation. Molecular Cell 2011; 43:853-66. 
46. Tian B, Manley JL. Alternative cleavage and polyadenylation: the long and short of it. Trends in 
Biochemical Sciences 2013; 38:312-20. 
47. Tollervey D, Caceres JF. RNA processing marches on. Cell 2000; 103:703-9. 
48. Proudfoot NJ, Furger A, Dye MJ. Integrating mRNA processing with transcription. Cell 2002; 
108:501-12. 
BIBLIOGRAPHY 
Page 89 of 92 
 
49. Moore MJ, Proudfoot NJ. Pre-mRNA processing reaches back to transcription and ahead to 
translation. Cell 2009; 136:688-700. 
50. Chang H, Lim J, Ha M, Kim VN. TAIL-seq: Genome-wide Determination of Poly(A) Tail Length 
and 3 ' End Modifications. Molecular Cell 2014; 53:1044-52. 
51. Subtelny AO, Eichhorn SW, Chen GR, Sive H, Bartel DP. Poly(A)-tail profiling reveals an 
embryonic switch in translational control. Nature 2014; 508:66-+. 
52. Zhang HB, Lee JY, Tian B. Biased alternative polyadenylation in human tissues. Genome Biology 
2005; 6. 
53. Colgan DF, Manley JL. Mechanism and regulation of mRNA polyadenylation. Genes & 
Development 1997; 11:2755-66. 
54. Shi Y, Di Giammartino DC, Taylor D, Sarkeshik A, Rice WJ, Yates JR, III, et al. Molecular 
Architecture of the Human Pre-mRNA 3 ' Processing Complex. Molecular Cell 2009; 33:365-76. 
55. Curinha A, Braz SO, Pereira-Castro I, Cruz A, Moreira A. Implications of polyadenylation in 
health and disease. Nucleus 2014; 5. 
56. Derti A, Garrett-Engele P, Macisaac KD, Stevens RC, Sriram S, Chen R, et al. A quantitative atlas 
of polyadenylation in five mammals. Genome Res 2012; 22:1173-83. 
57. Hoque M, Ji Z, Zheng D, Luo W, Li W, You B, et al. Analysis of alternative cleavage and 
polyadenylation by 3 ' region extraction and deep sequencing. Nature Methods 2013; 10:133-9. 
58. Elkon R, Ugalde AP, Agami R. Alternative cleavage and polyadenylation: extent, regulation and 
function. Nature Reviews Genetics 2013; 14:496-506. 
59. Sandberg R, Neilson JR, Sarma A, Sharp PA, Burge CB. Proliferating cells express mRNAs with 
shortened 3 ' untranslated regions and fewer microRNA target sites. Science 2008; 320:1643-7. 
60. Mayr C, Bartel DP. Widespread Shortening of 3 ' UTRs by Alternative Cleavage and 
Polyadenylation Activates Oncogenes in Cancer Cells. Cell 2009; 138:673-84. 
61. Ji Z, Tian B. Reprogramming of 3 ' Untranslated Regions of mRNAs by Alternative 
Polyadenylation in Generation of Pluripotent Stem Cells from Different Cell Types. Plos One 2009; 4. 
62. Ji Z, Lee JY, Pan Z, Jiang B, Tian B. Progressive lengthening of 3 ' untranslated regions of mRNAs 
by alternative polyadenylation during mouse embryonic development. Proceedings of the National 
Academy of Sciences of the United States of America 2009; 106:7028-33. 
63. Smibert P, Miura P, Westholm JO, Shenker S, May G, Duff MO, et al. Global Patterns of Tissue-
Specific Alternative Polyadenylation in Drosophila. Cell Reports 2012; 1:277-89. 
64. Miura P, Shenker S, Andreu-Agullo C, Westholm JO, Lai EC. Widespread and extensive 
lengthening of 3 ' UTRs in the mammalian brain. Genome Research 2013; 23:812-25. 
65. Glisovic T, Bachorik JL, Yong J, Dreyfuss G. RNA-binding proteins and post-transcriptional gene 
regulation. Febs Letters 2008; 582:1977-86. 
66. Ray D, Kazan H, Cook KB, Weirauch MT, Najafabadi HS, Li X, et al. A compendium of RNA-
binding motifs for decoding gene regulation. Nature 2013; 499:172-7. 
67. Hu W, Liu Y, Yan J. Microarray Meta-Analysis of RNA-Binding Protein Functions in Alternative 
Polyadenylation. Plos One 2014; 9. 
68. Miura P, Sanfilippo P, Shenker S, Lai EC. Alternative polyadenylation in the nervous system: To 
what lengths will 3 ' UTR extensions take us? Bioessays 2014; 36:766-77. 
69. Darnell RB. RNA Protein Interaction in Neurons. Annual Review of Neuroscience, Vol 36 2013; 
36:243-70. 
70. Jung H, Yoon BC, Holt CE. Axonal mRNA localization and local protein synthesis in nervous 
system assembly, maintenance and repair (vol 13, pg 308, 2012). Nature Reviews Neuroscience 2012; 
13. 
71. Larocque D, Galarneau A, Liu HN, Scott M, Almazan G, Richard S. Protection of p27(Kip1) mRNA 
by quaking RNA binding proteins promotes oligodendrocyte differentiation. Nature Neuroscience 2005; 
8:27-33. 
BIBLIOGRAPHY 
Page 90 of 92 
 
72. Dobson NR, Zhou Y-X, Flint NC, Armstrong RC. Musashi1 RNA-binding protein regulates 
oligodendrocyte lineage cell differentiation and survival. Glia 2008; 56:318-30. 
73. Laursen LS, Chan CW, Ffrench-Constant C. Translation of myelin basic protein mRNA in 
oligodendrocytes is regulated by integrin activation and hnRNP-K. Journal of Cell Biology 2011; 192:797-
811. 
74. Torvund-Jensen J, Stensgaard J, Fihl L, Reimer L, Laursen L. TRANSPORT AND TRANSLATION OF 
MBP MRNA IS DIFFERENTIALLY REGULATED BY DISTRINCT HNRNP PROTEINS. Glia 2013; 61:S143-S. 
75. White R, Gonsior C, Bauer NM, Kraemer-Albers E-M, Luhmann HJ, Trotter J. Heterogeneous 
Nuclear Ribonucleoprotein (hnRNP) F Is a Novel Component of Oligodendroglial RNA Transport Granules 
Contributing to Regulation of Myelin Basic Protein (MBP) Synthesis. Journal of Biological Chemistry 
2012; 287:1742-54. 
76. Ho JJD, Marsden PA. Competition and collaboration between RNA-binding proteins and 
microRNAs. Wiley Interdisciplinary Reviews-Rna 2014; 5:69-86. 
77. Ciafre SA, Galardi S. microRNAs and RNA-binding proteins A complex network of interactions 
and reciprocal regulations in cancer. Rna Biology 2013; 10:935-43. 
78. Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogenesis, function and 
decay. Nat Rev Genet 2010; 11:597-610. 
79. Leung AK, Sharp PA. Function and localization of microRNAs in mammalian cells. Cold Spring 
Harb Symp Quant Biol 2006; 71:29-38. 
80. Ameres SL, Zamore PD. Diversifying microRNA sequence and function. Nat Rev Mol Cell Biol 
2013; 14:475-88. 
81. Budde H, Schmitt S, Fitzner D, Opitz L, Salinas-Riester G, Simons M. Control of oligodendroglial 
cell number by the miR-17-92 cluster. Development 2010; 137:2127-32. 
82. Zhao X, He X, Han X, Yu Y, Ye F, Chen Y, et al. MicroRNA-Mediated Control of Oligodendrocyte 
Differentiation. Neuron 2010; 65:612-26. 
83. Lin S-T, Huang Y, Zhang L, Heng MY, Ptacek LJ, Fu Y-H. MicroRNA-23a promotes myelination in 
the central nervous system. Proceedings of the National Academy of Sciences of the United States of 
America 2013; 110:17468-73. 
84. Kearse M, Moir R, Wilson A, Stones-Havas S, Cheung M, Sturrock S, et al. Geneious Basic: An 
integrated and extendable desktop software platform for the organization and analysis of sequence 
data. Bioinformatics 2012; 28:1647-9. 
85. Cruz A, Teixeira D, Braz SO, Camacho R, Relvas JB, Moreira A. PBS Finder, a bioinformatic  tool 
for clustering analysis of protein binding to mRNA UTRs. Under revision in RNA, 2014. 
86. Cook KB, Kazan H, Zuberi K, Morris Q, Hughes TR. RBPDB: a database of RNA-binding 
specificities. Nucleic Acids Research 2011; 39:D301-D8. 
87. Paz I, Akerman M, Dror I, Kosti I, Mandel-Gutfreund Y. SFmap: a web server for motif analysis 
and prediction of splicing factor binding sites. Nucleic Acids Research 2010; 38:W281-W5. 
88. Betel D, Wilson M, Gabow A, Marks DS, Sander C. The microRNA.org resource: targets and 
expression. Nucleic Acids Research 2008; 36:D149-D53. 
89. Dweep H, Sticht C, Gretz N. In-Silico Algorithms for the Screening of Possible microRNA Binding 
Sites and Their Interactions. Current Genomics 2013; 14:127-36. 
90. McCarthy KD, Devellis J. PREPARATION OF SEPARATE ASTROGLIAL AND OLIGODENDROGLIAL 
CELL-CULTURES FROM RAT CEREBRAL TISSUE. Journal of Cell Biology 1980; 85:890-902. 
91. Syed YA, Baer AS, Lubec G, Hoeger H, Widhalm G, Kotter MR. Inhibition of oligodendrocyte 
precursor cell differentiation by myelin-associated proteins. Neurosurgical focus 2008; 24:E5-E. 
92. Gomes JR, Lobo AC, Melo CV, Inacio AR, Takano J, Iwata N, et al. Cleavage of the Vesicular 
GABA Transporter under Excitotoxic Conditions Is Followed by Accumulation of the Truncated 
Transporter in Nonsynaptic Sites. Journal of Neuroscience 2011; 31:4622-35. 
93. Barber RD, Harmer DW, Coleman RA, Clark BJ. GAPDH as a housekeeping gene: analysis of 
GAPDH mRNA expression in a panel of 72 human tissues. Physiological Genomics 2005; 21:389-95. 
BIBLIOGRAPHY 
Page 91 of 92 
 
94. Nelissen K, Smeets K, Mulder M, Hendriks JJA, Ameloot M. Selection of reference genes for 
gene expression studies in rat oligodendrocytes using quantitative real time PCR. Journal of 
Neuroscience Methods 2010; 187:78-83. 
95. Pinto PAB, Henriques T, Freitas MO, Martins T, Domingues RG, Wyrzykowska PS, et al. RNA 
polymerase II kinetics in polo polyadenylation signal selection. Embo Journal 2011; 30:2431-44. 
96. Chen D, Pan X, Xiao P, Farwell MA, Zhang B. Evaluation and Identification of Reliable Reference 
Genes for Pharmacogenomics, Toxicogenomics, and Small RNA Expression Analysis. Journal of Cellular 
Physiology 2011; 226:2469-77. 
97. Nunes NM, Li W, Tian B, Furger A. A functional human Poly(A) site requires only a potent DSE 
and an A-rich upstream sequence. Embo Journal 2010; 29:1523-36. 
98. Moreira A, Takagaki Y, Brackenridge S, Wollerton M, Manley JL, Proudfoot NJ. The upstream 
sequence element of the C2 complement poly(A) signal activates mRNA 3 ' end formation by two 
distinct mechanisms. Genes & Development 1998; 12:2522-34. 
99. Moreira A, Wollerton M, Monks J, Proudfoot NJ. UPSTREAM SEQUENCE ELEMENTS ENHANCE 
POLY(A) SITE EFFICIENCY OF THE C2 COMPLEMENT GENE AND ARE PHYLOGENETICALLY CONSERVED. 
Embo Journal 1995; 14:3809-19. 
100. Hall-Pogar T, Zhang H, Tian B, Lutz CS. Alternative polyadenylation of cyclooxygenase-2. Nucleic 
Acids Research 2005; 33:2565-79. 
101. Lianoglou S, Garg V, Yang JL, Leslie CS, Mayr C. Ubiquitously transcribed genes use alternative 
polyadenylation to achieve tissue-specific expression. Genes & Development 2013; 27:2380-96. 
102. Raff MC, Ffrenchconstant C, Miller RH. GLIAL-CELLS IN THE RAT OPTIC-NERVE AND SOME 
THOUGHTS ON REMYELINATION IN THE MAMMALIAN CNS. Journal of Experimental Biology 1987; 
132:35-41. 
103. Murk K, Suarez EMB, Cockbill LMR, Banks P, Hanley JG. The antagonistic modulation of Arp2/3 
activity by N-WASP, WAVE2 and PICK1 defines dynamic changes in astrocyte morphology. Journal of Cell 
Science 2013; 126:3873-83. 
104. An JJ, Gharami K, Liao G-Y, Woo NH, Lau AG, Vanevski F, et al. Distinct role of long 3 ' UTR BDNF 
mRNA in spine morphology and synaptic plasticity in hippocampal neurons. Cell 2008; 134:175-87. 
105. Nakielny S, Dreyfuss G. Transport of proteins and RNAs in and out of the nucleus. Cell 1999; 
99:677-90. 
106. EdwaldsGilbert G, Veraldi KL, Milcarek C. Alternative poly(A) site selection in complex 
transcription units: Means to an end? Nucleic Acids Research 1997; 25:2547-61. 
107. Blechingberg J, Lykke-Andersen S, Jensen TH, Jorgensen AL, Nielsen AL. Regulatory mechanisms 
for 3'-end alternative splicing and polyadenylation of the glial fibrillary acidic protein, GFAP, transcript. 
Nucleic Acids Research 2007; 35:7636-50. 
108. Li Z, Aizenman CD, Cline HT. Regulation of rho GTPases by crosstalk and neuronal activity in 
vivo. Neuron 2002; 33:741-50. 
109. Tolias KF, Bikoff JB, Burette A, Paradis S, Harrar D, Tavazoie S, et al. The Rac1-GEF Tiam1 
couples the NMDA receptor to the activity-dependent development of dendritic arbors and spines. 
Neuron 2005; 45:525-38. 
110. Wang L, Yi R. 3 ' UTRs take a long shot in the brain. Bioessays 2014; 36:39-45. 
111. Licatalosi DD, Mele A, Fak JJ, Ule J, Kayikci M, Chi SW, et al. HITS-CLIP yields genome-wide 
insights into brain alternative RNA processing. Nature 2008; 456:464-U22. 
112. Castelo-Branco P, Furger A, Wollerton M, Smith C, Moreira A, Proudfoot N. Polypyrimidine tract 
binding protein modulates efficiency of polyadenylation. Molecular and Cellular Biology 2004; 24:4174-
83. 
113. Boutz PL, Stoilov P, Li Q, Lin C-H, Chawla G, Ostrow K, et al. A post-transcriptional regulatory 
switch in polypyrimidine tract-binding proteins reprograms alternative splicing in developing neurons. 
Genes & Development 2007; 21:1636-52. 
BIBLIOGRAPHY 
Page 92 of 92 
 
114. Irwin N, Baekelandt V, Goritchenko L, Benowitz LI. Identification of two proteins that bind to a 
pyrimidine-rich sequence in the 3'-untranslated region of GAP-43 mRNA. Nucleic Acids Research 1997; 
25:1281-8. 
115. Tillmar L, Welsh N. Glucose-induced binding of the polypyrimidine tract-binding protein (PTB) 
to the 3 '-untranslated region of the insulin mRNA (ins-PRS) is inhibited by rapamycin. Molecular and 
Cellular Biochemistry 2004; 260:85-90. 
116. Xue Y, Ouyang K, Huang J, Zhou Y, Ouyang H, Li H, et al. Direct Conversion of Fibroblasts to 
Neurons by Reprogramming PTB-Regulated MicroRNA Circuits. Cell 2013; 152:82-96. 
117. Makeyev EV, Zhang J, Carrasco MA, Maniatis T. The MicroRNA miR-124 promotes neuronal 
differentiation by triggering brain-specific alternative Pre-mRNA splicing. Molecular Cell 2007; 27:435-
48. 
118. Okano HJ, Darnell RB. A hierarchy of Hu RNA binding proteins in developing and adult neurons. 
Journal of Neuroscience 1997; 17:3024-37. 
119. Hilgers V, Lemke SB, Levine M. ELAV mediates 3 ' UTR extension in the Drosophila nervous 
system. Genes & Development 2012; 26:2259-64. 
120. Pascale A, Amadio M, Quattrone A. Defining a neuron: neuronal ELAV proteins. Cellular and 
Molecular Life Sciences 2008; 65:128-40. 
121. Bronicki LM, Jasmin BJ. Emerging complexity of the HuD/ELAVl4 gene; implications for neuronal 
development, function, and dysfunction. Rna-a Publication of the Rna Society 2013; 19:1019-37. 
122. Lyabin DN, Eliseeva IA, Ovchinnikov LP. YB-1 protein: functions and regulation. Wiley 
Interdisciplinary Reviews-Rna 2014; 5:95-110. 
123. Marks PW, Kwiatkowski DJ. Genomic organization and chromosomal location of murine cdc42. 
Genomics 1996; 38:13-8. 
124. Horn M, Baumann R, Pereira JA, Sidiropoulos PNM, Somandin C, Welzl H, et al. Myelin is 
dependent on the Charcot-Marie-Tooth Type 4H disease culprit protein FRABIN/FGD4 in Schwann cells. 
Brain 2012; 135:3567-83. 
125. Tamim S, Vo DT, Uren PJ, Qiao M, Bindewald E, Kasprzak WK, et al. Genomic Analyses Reveal 
Broad Impact of miR-137 on Genes Associated with Malignant Transformation and Neuronal 
Differentiation in Glioblastoma Cells. Plos One 2014; 9. 
126. Fu M-g, Li S, Yu T-t, Qian L-j, Cao R-s, Zhu H, et al. Differential expression of miR-195 in 
esophageal squamous cell carcinoma and miR-195 expression inhibits tumor cell proliferation and 
invasion by targeting of Cdc42. Febs Letters 2013; 587:3471-9. 
 
